<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Merck &amp; Co. - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"XphvFQpAICAAAEwSbkYAAADF","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Merck_\u0026_Co.","wgTitle":"Merck \u0026 Co.","wgCurRevisionId":950921372,"wgRevisionId":950921372,"wgArticleId":30874304,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Merck_\u0026_Co.","wgRelevantArticleId":30874304,"wgIsProbablyEditable":!0,"wgRelevantPageIsProbablyEditable":!0,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":!0,"wgMediaViewerEnabledByDefault":!0,
"wgPopupsReferencePreviews":!1,"wgPopupsConflictsWithNavPopupGadget":!1,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFMode":"stable","wgMFAmc":!1,"wgMFAmcOutreachActive":!1,"wgMFAmcOutreachUserEligible":!1,"wgMFLazyLoadImages":!0,"wgMFDisplayWikibaseDescriptions":{"search":!0,"nearby":!0,"watchlist":!0,"tagline":!1},"wgMFIsPageContentModelEditable":!0,"wgWMESchemaEditAttemptStepOversample":!1,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q247489","wgCentralAuthMobileDomain":!0,"wgEditSubmitButtonLabelPublish":!0,"wgMinervaPermissions":{"watch":!0,"talk":!1},"wgMinervaFeatures":{"beta":!1,"mobileOptionsLink":!0,"categories":!1,"pageIssues":!0,"talkAtTop":!1,"historyInPageActions":!1,"overflowSubmenu":!1,"tabsOnSpecials":!1,"personalMenu":!1,"mainMenuExpanded":!1,"simplifiedTalk":!0},"wgMinervaDownloadNamespaces":[0]};RLSTATE={
"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.minerva.base.styles":"ready","skins.minerva.content.styles":"ready","skins.minerva.content.styles.images":"ready","mediawiki.hlist":"ready","mediawiki.ui.icon":"ready","mediawiki.ui.button":"ready","skins.minerva.icons.wikimedia":"ready","skins.minerva.mainMenu.icons":"ready","skins.minerva.mainMenu.styles":"ready","mobile.init.styles":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["site","mediawiki.page.startup","skins.minerva.options","skins.minerva.scripts","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","mobile.init","ext.relatedArticles.readMore.bootstrap","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","mw.externalguidance.init","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.wikimediaBadges%7Cmediawiki.hlist%7Cmediawiki.ui.button%2Cicon%7Cmobile.init.styles%7Cskins.minerva.base.styles%7Cskins.minerva.content.styles%7Cskins.minerva.content.styles.images%7Cskins.minerva.icons.wikimedia%7Cskins.minerva.mainMenu.icons%2Cstyles&amp;only=styles&amp;skin=minerva"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=minerva&amp;target=mobile"></script>
<meta name="generator" content="MediaWiki 1.35.0-wmf.27"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta name="theme-color" content="#eaecf0"/>
<meta name="viewport" content="initial-scale=1.0, user-scalable=yes, minimum-scale=0.25, maximum-scale=5.0, width=device-width"/>
<link rel="manifest" href="/w/api.php?action=webapp-manifest"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Merck_%26_Co.&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Merck_%26_Co.&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Merck_%26_Co."/>
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Merck_Co rootpage-Merck_Co stable issues-group-B skin-minerva action-view">
<div id="mw-mf-viewport">
	<div id="mw-mf-page-center">
		<a class="mw-mf-page-center__mask" href="#"></a>
		<header class="header-container header-chrome">
			<form class="header" action="/w/index.php" method="get">
				<nav class="navigation-drawer toggle-list view-border-box">
					<input type="checkbox" id="main-menu-input" class="toggle-list__checkbox" role="button" aria-labelledby="mw-mf-main-menu-button">
					<label for="main-menu-input" id="mw-mf-main-menu-button"
						class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-menu-base20 mw-ui-icon-flush-left toggle-list__toggle"
						title="Open main menu" data-event-name="ui.mainmenu">Open main menu</label>
					<div id="mw-mf-page-left" class="menu toggle-list__list view-border-box">
	<ul id="p-navigation">
			<li class="">
			    <a href="/wiki/Main_Page" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-home" data-event-name="menu.home"><span>Home</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Special:Random#/random" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-die " data-event-name="menu.random"><span>Random</span></a>
			</li>
			<li class="jsonly">
			    <a href="/wiki/Special:Nearby" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-mapPin nearby" data-event-name="menu.nearby"><span>Nearby</span></a>
			</li>
	</ul>
	<ul id="p-personal">
			<li class="">
			    <a href="/w/index.php?title=Special:UserLogin&amp;returnto=Merck+%26+Co." class="menu__item--login mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-logIn " data-event-name="menu.login"><span>Log in</span></a>
			</li>
	</ul>
	<ul id="pt-preferences">
			<li class="jsonly">
			    <a href="/w/index.php?title=Special:MobileOptions&amp;returnto=Merck+%26+Co." class="menu__item--settings mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-settings " data-event-name="menu.settings"><span>Settings</span></a>
			</li>
	</ul>
	<ul class="hlist">
			<li class="">
			    <a href="/wiki/Wikipedia:About" class="" data-event-name=""><span>About Wikipedia</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Wikipedia:General_disclaimer" class="" data-event-name=""><span>Disclaimers</span></a>
			</li>
	</ul>
</div>

					<label class="main-menu-mask" for="main-menu-input"></label>
				</nav>
				<div class="branding-box">
					<a href="/wiki/Main_Page">
						<span><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></span>
						
					</a>
				</div>
				<div class="search-box">
					<input class="search mw-ui-background-icon-search skin-minerva-search-trigger" type="search" name="search" id="searchInput"
						autocomplete="off" placeholder="Search Wikipedia" aria-label="Search Wikipedia"
						value="">
				</div>
				<nav class="minerva-user-navigation" aria-label="User navigation">
					<div><button id="searchIcon" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-search-base20 skin-minerva-search-trigger" type="submit">Search</button></div>
					
				</nav>
			</form>
		</header>
		<main id="content" class="mw-body">
			<div class="banner-container">
			<div id="siteNotice"></div>
			</div>
			
			<div class="pre-content heading-holder">
				<div class="page-heading">
					<h1 id="section_0">Merck &amp; Co.</h1>
					<div class="tagline"></div>
				</div>
				<nav class="page-actions-menu">
	<ul id="page-actions" class="page-actions-menu__list">
		<li id="language-selector" class="page-actions-menu__list-item">
				<a id="" href="/wiki/Special:MobileLanguages/Merck_%26_Co." class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-language-base20 mw-ui-icon-with-label-desktop language-selector"
					data-mw="interface"
					data-event-name="menu.languages" role="button" title="Language">Language</a>
		</li>
		<li id="page-actions-watch" class="page-actions-menu__list-item">
				<a id="ca-watch" href="/w/index.php?title=Special:UserLogin&amp;returnto=Merck+%26+Co." class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-star-base20 mw-ui-icon-with-label-desktop watch-this-article mw-watchlink menu__item--page-actions-watch"
					data-mw="interface"
					data-event-name="menu.watch" role="button" title="Watch">Watch</a>
		</li>
		<li id="page-actions-edit" class="page-actions-menu__list-item">
				<a id="ca-edit" href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=0" class="edit-page menu__item--page-actions-edit mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 mw-ui-icon-with-label-desktop"
					data-mw="interface"
					data-event-name="menu.edit" role="button" title="Edit the lead section of this page">Edit</a>
		</li>
	</ul>
</nav>
<!-- version 1.0.2 (change every time you update a partial) -->

				
				
				<div class="minerva__subtitle"></div>
			</div>
			
			<div id="bodyContent" class="content"><div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><script>function mfTempOpenSection(id){var block=document.getElementById("mf-section-"+id);block.className+=" open-block";block.previousSibling.className+=" open-block";}</script><div class="mw-parser-output"><section class="mf-section-0" id="mf-section-0">
<div role="note" class="hatnote navigation-not-searchable">Not to be confused with the <a href="/wiki/Merck_Group" title="Merck Group">Merck Group</a> (Merck KGaA), a distinct but historically related company based in Germany. It does business as EMD in the United States and Canada.</div>
<p><b>Merck &amp; Co., Inc.</b>, <a href="/wiki/Trade_name" title="Trade name">d.b.a.</a> <b>Merck Sharp &amp; Dohme</b> (<b>MSD</b>) outside the United States and Canada, is an American <a href="/wiki/Multinational_corporation" title="Multinational corporation">multinational</a> <a href="/wiki/Pharmaceutical_company" class="mw-redirect" title="Pharmaceutical company">pharmaceutical company</a> and one of the largest <a href="/wiki/Pharmaceutical_companies" class="mw-redirect" title="Pharmaceutical companies">pharmaceutical companies</a> in the world. Merck is incorporated in New Jersey.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4">[4]</a></sup></p><table class="infobox vcard" style="width:22em"><caption class="fn org">Merck &amp; Co., Inc.</caption><tbody><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:Merck_Logo.svg" class="image"><img alt="Merck Logo.svg" src="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Merck_Logo.svg/200px-Merck_Logo.svg.png" decoding="async" width="200" height="60" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Merck_Logo.svg/300px-Merck_Logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/94/Merck_Logo.svg/400px-Merck_Logo.svg.png 2x" data-file-width="207" data-file-height="62"></a><div>The current Merck &amp; Co. logo, designed by <a href="/wiki/Chermayeff_%26_Geismar_%26_Haviv" title="Chermayeff &amp; Geismar &amp; Haviv">Chermayeff &amp; Geismar</a> in 1965. The "MERCK" writing is used in U.S. and Canada; outside these countries "MSD" writing is used.</div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/List_of_legal_entity_types_by_country" title="List of legal entity types by country">Type</a></div></th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Public_company" title="Public company">Public</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></th><td style="line-height: 1.35em;"><div class="plainlist"><ul><li><a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">NYSE</a>: <a rel="nofollow" class="external text" href="https://www.nyse.com/quote/XNYS:MRK">MRK</a></li><li><a href="/wiki/DJIA" class="mw-redirect" title="DJIA">DJIA</a> component</li><li><a href="/wiki/S%26P_100" title="S&amp;P 100">S&amp;P 100</a> component</li><li><a href="/wiki/S%26P_500" class="mw-redirect" title="S&amp;P 500">S&amp;P 500</a> component</li></ul></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/International_Securities_Identification_Number" title="International Securities Identification Number">ISIN</a></th><td style="line-height: 1.35em;"><span class="plainlinks nourlexpansion"><a class="external text" href="https://tools.wmflabs.org/isin/?language=en&amp;isin=US58933Y1055">US58933Y1055 </a><a href="https://www.wikidata.org/wiki/Q247489?uselang=en#P946" title="Edit this on Wikidata"><img alt="Edit this on Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20"></a></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Industry</th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Pharmaceutical_company" class="mw-redirect" title="Pharmaceutical company">Pharmaceuticals</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Predecessor</th><td style="line-height: 1.35em;">Schering-Plough <a href="https://www.wikidata.org/wiki/Q247489?uselang=en#P155" title="Edit this on Wikidata"><img alt="Edit this on Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20"></a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founded</th><td style="line-height: 1.35em;">1891<span class="noprint">; 129 years ago</span><span style="display:none"> (<span class="bday dtstart published updated">1891</span>)</span> as a subsidiary of <a href="/wiki/Merck_Group" title="Merck Group">Merck</a> (founded 1668)<br>1917 as an independent company</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founders</th><td class="agent" style="line-height: 1.35em;">George Merck</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Headquarters</th><td class="label" style="line-height: 1.35em;"><a href="/wiki/Kenilworth,_New_Jersey" title="Kenilworth, New Jersey">Kenilworth, New Jersey</a>, United States</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Area served</div></th><td style="line-height: 1.35em;">Worldwide</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Key people</div></th><td class="agent" style="line-height: 1.35em;"><div class="plainlist"><ul><li><span class="nowrap"><a href="/wiki/Kenneth_Frazier" title="Kenneth Frazier">Kenneth C. Frazier</a></span></li><li><span class="nowrap"><span style="font-size:85%;">(<a href="/wiki/Chairman" class="mw-redirect" title="Chairman">Chairman</a>, <a href="/wiki/President_(corporate_title)" title="President (corporate title)">President</a> &amp; <a href="/wiki/CEO" class="mw-redirect" title="CEO">CEO</a>)</span><sup id="cite_ref-10-K_2016_1-0" class="reference"><a href="#cite_note-10-K_2016-1">[1]</a></sup></span></li><li><span class="nowrap">Robert M. Davis</span></li><li><span class="nowrap"><span style="font-size:85%;">(<a href="/wiki/Vice_president#In_business" title="Vice president">Vice President</a> &amp; <a href="/wiki/CFO" class="mw-redirect" title="CFO">CFO</a>)</span><sup id="cite_ref-10-K_2016_1-1" class="reference"><a href="#cite_note-10-K_2016-1">[1]</a></sup><sup id="cite_ref-Johnson2018_2-0" class="reference"><a href="#cite_note-Johnson2018-2">[2]</a></sup></span></li></ul></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Products</th><td style="line-height: 1.35em;"><a href="/wiki/Gardasil" title="Gardasil">Gardasil</a><br><a href="/wiki/Montelukast" title="Montelukast">Singulair</a><br><a href="/wiki/Finasteride" title="Finasteride">Propecia/Proscar</a><br><a href="/wiki/Simvastatin" title="Simvastatin">Zocor</a>  <a href="/wiki/Vioxx" class="mw-redirect" title="Vioxx">Vioxx</a>  <a href="/wiki/Fosamax" class="mw-redirect" title="Fosamax">Fosamax</a> <a href="/wiki/Keytruda" class="mw-redirect" title="Keytruda">Keytruda</a> <a href="/wiki/Januvia" class="mw-redirect" title="Januvia">Januvia</a>   <a href="/wiki/Imipenem/cilastatin" title="Imipenem/cilastatin">Primaxin</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Revenue</th><td style="line-height: 1.35em;"><span class="nowrap"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <a href="/wiki/US%24" class="mw-redirect" title="US$">US$</a>42.294 billion <span style="font-size:85%;">(2018)</span><sup id="cite_ref-10-K_2017_3-0" class="reference"><a href="#cite_note-10-K_2017-3">[3]</a></sup></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Earnings_before_interest_and_taxes" title="Earnings before interest and taxes">Operating income</a></div></th><td style="line-height: 1.35em;"><span class="nowrap"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> US$8.299 billion <span style="font-size:85%;">(2018)</span><sup id="cite_ref-10-K_2017_3-1" class="reference"><a href="#cite_note-10-K_2017-3">[3]</a></sup></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Net_income" title="Net income">Net income</a></div></th><td style="line-height: 1.35em;"><span class="nowrap"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> US$6.220 billion <span style="font-size:85%;">(2018)</span><sup id="cite_ref-10-K_2017_3-2" class="reference"><a href="#cite_note-10-K_2017-3">[3]</a></sup></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Asset" title="Asset">Total assets</a></span></th><td style="line-height: 1.35em;"><span class="nowrap"><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> US$82.637 billion <span style="font-size:85%;">(2018)</span><sup id="cite_ref-10-K_2017_3-3" class="reference"><a href="#cite_note-10-K_2017-3">[3]</a></sup></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Equity_(finance)" title="Equity (finance)">Total equity</a></span></th><td style="line-height: 1.35em;"><span class="nowrap"><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> US$26.701 billion <span style="font-size:85%;">(2018)</span><sup id="cite_ref-10-K_2017_3-4" class="reference"><a href="#cite_note-10-K_2017-3">[3]</a></sup></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Number of employees</div></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> ~69,000 <span style="font-size:85%;">(2018)</span><sup id="cite_ref-Johnson2018_2-1" class="reference"><a href="#cite_note-Johnson2018-2">[2]</a></sup><sup id="cite_ref-10-K_2017_3-5" class="reference"><a href="#cite_note-10-K_2017-3">[3]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Website</th><td style="line-height: 1.35em;"><span class="url"><a rel="nofollow" class="external text" href="http://merck.com">merck<wbr></wbr>.com</a></span></td></tr></tbody></table><p>The company was established in 1891 as the United States subsidiary of the German company <a href="/wiki/Merck_Group" title="Merck Group">Merck</a>, which was founded in 1668 by the <a href="/wiki/Merck_family" title="Merck family">Merck family</a>. Merck &amp; Co. was <a href="/wiki/Expropriation" class="mw-redirect" title="Expropriation">expropriated</a> by the US government during <a href="/wiki/World_War_I" title="World War I">World War I</a> and subsequently established as an independent American company in 1917. While it operates as Merck &amp; Co. in the United States and Canada, the original Merck based in Darmstadt holds the rights to the Merck name everywhere else. Merck &amp; Co. is the world's seventh largest pharmaceutical company by <a href="/wiki/Market_capitalization" title="Market capitalization">market capitalization</a> and revenue. Its headquarters is located in <a href="/wiki/Kenilworth,_New_Jersey" title="Kenilworth, New Jersey">Kenilworth, New Jersey</a>.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5">[5]</a></sup> The company ranked No. 78 in the 2018 <a href="/wiki/Fortune_500" title="Fortune 500">Fortune 500</a> list of the largest United States corporations by total revenue.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6">[6]</a></sup></p><p>Merck &amp; Co. publishes <i><a href="/wiki/The_Merck_Manuals" title="The Merck Manuals">The Merck Manuals</a></i>, a series of medical reference books for physicians, nurses, technicians, and veterinarians. These include the <i><a href="/wiki/Merck_Manual_of_Diagnosis_and_Therapy" title="Merck Manual of Diagnosis and Therapy">Merck Manual of Diagnosis and Therapy</a></i>, the world's best-selling medical reference. <i><a href="/wiki/The_Merck_Index" class="mw-redirect" title="The Merck Index">The Merck Index</a></i>, a compendium of chemical compounds, was formerly published by Merck &amp; Co. before being acquired by the <a href="/wiki/Royal_Society_of_Chemistry" title="Royal Society of Chemistry">Royal Society of Chemistry</a> in 2012.
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none"><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul><li class="toclevel-1 tocsection-1"><a href="#Company_history"><span class="tocnumber">1</span> <span class="toctext">Company history</span></a>
<ul><li class="toclevel-2 tocsection-2"><a href="#Roots_and_early_history"><span class="tocnumber">1.1</span> <span class="toctext">Roots and early history</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Nationalization"><span class="tocnumber">1.2</span> <span class="toctext">Nationalization</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#1950_to_2000"><span class="tocnumber">1.3</span> <span class="toctext">1950 to 2000</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#2001_to_2019"><span class="tocnumber">1.4</span> <span class="toctext">2001 to 2019</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#2020_to_Present"><span class="tocnumber">1.5</span> <span class="toctext">2020 to Present</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#%22Merck%22_name_legal_dispute"><span class="tocnumber">1.6</span> <span class="toctext">"Merck" name legal dispute</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-8"><a href="#Acquisition_history"><span class="tocnumber">2</span> <span class="toctext">Acquisition history</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#Corporate_governance"><span class="tocnumber">3</span> <span class="toctext">Corporate governance</span></a></li>
<li class="toclevel-1 tocsection-10"><a href="#Products"><span class="tocnumber">4</span> <span class="toctext">Products</span></a>
<ul><li class="toclevel-2 tocsection-11"><a href="#Current"><span class="tocnumber">4.1</span> <span class="toctext">Current</span></a>
<ul><li class="toclevel-3 tocsection-12"><a href="#Other_products"><span class="tocnumber">4.1.1</span> <span class="toctext">Other products</span></a></li>
</ul></li>
<li class="toclevel-2 tocsection-13"><a href="#Legacy_products"><span class="tocnumber">4.2</span> <span class="toctext">Legacy products</span></a>
<ul><li class="toclevel-3 tocsection-14"><a href="#Vaccines"><span class="tocnumber">4.2.1</span> <span class="toctext">Vaccines</span></a></li>
<li class="toclevel-3 tocsection-15"><a href="#Thiazide_anti-hypertensives"><span class="tocnumber">4.2.2</span> <span class="toctext">Thiazide anti-hypertensives</span></a></li>
<li class="toclevel-3 tocsection-16"><a href="#First_statin"><span class="tocnumber">4.2.3</span> <span class="toctext">First statin</span></a></li>
<li class="toclevel-3 tocsection-17"><a href="#Antibacterials"><span class="tocnumber">4.2.4</span> <span class="toctext">Antibacterials</span></a></li>
<li class="toclevel-3 tocsection-18"><a href="#Vioxx"><span class="tocnumber">4.2.5</span> <span class="toctext">Vioxx</span></a></li>
<li class="toclevel-3 tocsection-19"><a href="#Mectizan"><span class="tocnumber">4.2.6</span> <span class="toctext">Mectizan</span></a></li>
<li class="toclevel-3 tocsection-20"><a href="#Fosamax"><span class="tocnumber">4.2.7</span> <span class="toctext">Fosamax</span></a></li>
</ul></li>
</ul></li>
<li class="toclevel-1 tocsection-21"><a href="#Society_and_culture"><span class="tocnumber">5</span> <span class="toctext">Society and culture</span></a>
<ul><li class="toclevel-2 tocsection-22"><a href="#Patient_assistance_programs"><span class="tocnumber">5.1</span> <span class="toctext">Patient assistance programs</span></a></li>
<li class="toclevel-2 tocsection-23"><a href="#Restructurings"><span class="tocnumber">5.2</span> <span class="toctext">Restructurings</span></a></li>
<li class="toclevel-2 tocsection-24"><a href="#Sham_medical_journal"><span class="tocnumber">5.3</span> <span class="toctext">Sham medical journal</span></a></li>
<li class="toclevel-2 tocsection-25"><a href="#Hilleman_Laboratories"><span class="tocnumber">5.4</span> <span class="toctext">Hilleman Laboratories</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#Medicaid_overbilling"><span class="tocnumber">5.5</span> <span class="toctext">Medicaid overbilling</span></a></li>
<li class="toclevel-2 tocsection-27"><a href="#Environmental_record"><span class="tocnumber">5.6</span> <span class="toctext">Environmental record</span></a></li>
<li class="toclevel-2 tocsection-28"><a href="#MSD_for_Mothers"><span class="tocnumber">5.7</span> <span class="toctext">MSD for Mothers</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-29"><a href="#See_also"><span class="tocnumber">6</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-30"><a href="#Notes_and_references"><span class="tocnumber">7</span> <span class="toctext">Notes and references</span></a></li>
<li class="toclevel-1 tocsection-31"><a href="#External_links"><span class="tocnumber">8</span> <span class="toctext">External links</span></a></li>
</ul></div>

</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(1)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Company_history">Company history</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=1" title="Edit section: Company history" data-section="1" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-1 collapsible-block" id="mf-section-1">
<h3 class="in-block"><span class="mw-headline" id="Roots_and_early_history">Roots and early history</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=2" title="Edit section: Roots and early history" data-section="2" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Merck_Group" title="Merck Group">Merck Group</a></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:ENGEL_APHOTHEKE.png" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/eb/ENGEL_APHOTHEKE.png/220px-ENGEL_APHOTHEKE.png" decoding="async" width="220" height="147" class="thumbimage" data-file-width="3542" data-file-height="2369"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 147px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/e/eb/ENGEL_APHOTHEKE.png/220px-ENGEL_APHOTHEKE.png" data-alt="" data-width="220" data-height="147" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:ENGEL_APHOTHEKE.png" class="internal" title="Enlarge"></a></div>The Angel Pharmacy in <a href="/wiki/Darmstadt" title="Darmstadt">Darmstadt</a>, the beginning of the <a href="/wiki/Merck_Group" title="Merck Group">Merck</a> company</div></div></div>
<p>Merck &amp; Co. traces its origins to its original German parent company <a href="/wiki/Merck_Group" title="Merck Group">Merck</a>, which was established by the <a href="/wiki/Merck_family" title="Merck family">Merck family</a> in 1668 when <a href="/wiki/Friedrich_Jacob_Merck" title="Friedrich Jacob Merck">Friedrich Jacob Merck</a> purchased a drug store in <a href="/wiki/Darmstadt" title="Darmstadt">Darmstadt</a>.<sup id="cite_ref-:1_7-0" class="reference"><a href="#cite_note-:1-7">[7]</a></sup><sup id="cite_ref-:2_8-0" class="reference"><a href="#cite_note-:2-8">[8]</a></sup> In the 19th century, the Merck company evolved from a pharmacy to a major pharmaceutical company and introduced the commercial manufacture of <a href="/wiki/Morphine" title="Morphine">morphine</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (April 2020)">citation needed</span></a></i>]</sup></p><p>In 1891, family member George (Georg) Merck emigrated to the United States and set up Merck &amp; Co. in New York as the US subsidiary of the family company.<sup id="cite_ref-:1_7-1" class="reference"><a href="#cite_note-:1-7">[7]</a></sup><sup id="cite_ref-:2_8-1" class="reference"><a href="#cite_note-:2-8">[8]</a></sup> Merck &amp; Co. operated from 1891 to 1917 as the US subsidiary of the <a href="/wiki/Merck_Group" title="Merck Group">Merck Group</a>.<sup id="cite_ref-:2_8-2" class="reference"><a href="#cite_note-:2-8">[8]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Nationalization">Nationalization</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=3" title="Edit section: Nationalization" data-section="3" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>After the U.S entered <a href="/wiki/World_War_I" title="World War I">World War I</a>, the Merck Group's US subsidiary Merck &amp; Co. was confiscated under the <a href="/wiki/Trading_with_the_Enemy_Act_of_1917" title="Trading with the Enemy Act of 1917">Trading with the Enemy Act of 1917</a>.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9">[9]</a></sup> Company head <a href="/wiki/George_W._Merck" title="George W. Merck">George W. Merck</a> purchased back the stock in 1919, but U.S. Merck remained a separate company from its former German parent.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (April 2020)">citation needed</span></a></i>]</sup> Merck &amp; Co. holds the trademark rights to the "Merck" name in the United States and Canada, while its former parent company retains the rights in the rest of the world.<sup id="cite_ref-apc1919_10-0" class="reference"><a href="#cite_note-apc1919-10">[10]</a></sup><sup id="cite_ref-genengnews.com_11-0" class="reference"><a href="#cite_note-genengnews.com-11">[11]</a></sup></p><p>In 1929, <a href="/wiki/H._K._Mulford_Company" title="H. K. Mulford Company">H. K. Mulford Company</a> merged with Sharp and Dohme, Inc. and brought vaccine technology, including immunization of cavalry horses in World War I and delivery of a diphtheria antitoxin to Merck &amp; Co.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12">[12]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="1950_to_2000">1950 to 2000</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=4" title="Edit section: 1950 to 2000" data-section="4" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 1953, Merck &amp; Co. merged with Philadelphia-based Sharp &amp; Dohme, Inc.,  becoming the largest US drugmaker.<sup class="noprint Inline-Template"><span style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title=" Dead link since April 2020">dead link</span></a></i>]</span></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13">[13]</a></sup><sup id="cite_ref-:1_7-2" class="reference"><a href="#cite_note-:1-7">[7]</a></sup> The combined company kept the trade name Merck in the United States and Canada, and as Merck Sharp &amp; Dohme (MSD) outside North America.<sup id="cite_ref-:3_14-0" class="reference"><a href="#cite_note-:3-14">[14]</a></sup></p><p>In 1965 Merck &amp; Co. acquired <a href="/wiki/Charles_Frosst" title="Charles Frosst">Charles E. Frosst</a> Ltd. of <a href="/wiki/Montreal" title="Montreal">Montreal, Quebec</a>, Canada (founded 1899) and created Merck-Frosst Canada, Inc., as its Canadian subsidiary and pharmaceutical research facility.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (April 2020)">citation needed</span></a></i>]</sup> Merck &amp; Co. closed this facility in July 2010,<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">[15]</a></sup> and the company was renamed Merck Canada in 2011.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (April 2020)">citation needed</span></a></i>]</sup></p><p>The company was incorporated in New Jersey in 1970.<sup id="cite_ref-2013-10K_16-0" class="reference"><a href="#cite_note-2013-10K-16">[16]</a></sup> It has an operating subsidiary, KBI Inc., which was originally formed as a joint venture with <a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZeneca</a>.<sup id="cite_ref-2013-10K_16-1" class="reference"><a href="#cite_note-2013-10K-16">[16]</a></sup> During the late 1980s and 1990s, the company also established joint ventures with <a href="/wiki/DuPont" title="DuPont">DuPont</a> to access research and development expertise, and with <a href="/wiki/Johnson_%26_Johnson" title="Johnson &amp; Johnson">Johnson &amp; Johnson</a> to sell over-the-counter consumer medications.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (April 2020)">citation needed</span></a></i>]</sup> In November 1993, Merck &amp; Co. completed a $6 billion purchase of Medco Containment Services Inc.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17">[17]</a></sup> Merck &amp; Co. spun Medco off ten years later.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18">[18]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="2001_to_2019">2001 to 2019</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=5" title="Edit section: 2001 to 2019" data-section="5" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In November 2009, Merck &amp; Co. announced that it would merge with competitor <a href="/wiki/Schering-Plough" title="Schering-Plough">Schering-Plough</a> in a US$41 billion deal.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19">[19]</a></sup><sup id="cite_ref-20" class="reference"><a href="#cite_note-20">[20]</a></sup> Although Merck &amp; Co. was in reality acquiring Schering-Plough, the purchase was declared a "reverse merger", in which "Old" Merck &amp; Co. was renamed Merck Sharp &amp; Dohme, and Schering-Plough renamed as "Merck &amp; Co., Inc.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">[21]</a></sup> The maneuver was an attempt to preserve Schering-Plough's rights to market <a href="/wiki/Remicade" class="mw-redirect" title="Remicade">Remicade</a>, which was ultimately decided by arbitration.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22">[22]</a></sup> The merger was completed on November 4, 2009.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">[23]</a></sup> As of 2015<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Merck_%26_Co.&amp;action=edit">[update]</a></sup>, Merck Sharp &amp; Dohme remains a subsidiary of the Merck &amp; Co. parent.<sup id="cite_ref-:0_24-0" class="reference"><a href="#cite_note-:0-24">[24]</a></sup></p><p>As of December 2013, the US company had approximately 76,000 employees in 120 countries with 31 factories worldwide. It is one of the world's seven largest pharmaceutical companies. The Merck Company Foundation has distributed more than $480 million to educational and non-profit organizations since it was founded in 1957 (and $740 million in overall charitable distributions).<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">[25]</a></sup><sup id="cite_ref-26" class="reference"><a href="#cite_note-26">[26]</a></sup> On December 7, 2012, the foundation announced that it was ending its donations to the <a href="/wiki/Boy_Scouts_of_America" title="Boy Scouts of America">Boy Scouts of America</a> because of "its policy that excludes members on the basis of sexual orientation", which "directly conflicts with the Merck Foundation's giving guidelines".<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">[27]</a></sup> In October 2013, Merck &amp; Co. announced it would cut 8,500 jobs in an attempt to cut $2.5bn (£1.5bn) from its costs by 2015. The company's shares rose 2.35% to <a href="/wiki/United_States_dollar" title="United States dollar">US$</a>48.73 in New York trading after it announced the cuts. The new losses, combined with 7,500 job cuts announced in 2011 and 2012, amount in total to 20% of its workforce.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">[28]</a></sup></p><p>In June 2014 Merck &amp; Co. announced its acquisition of Idenix Pharmaceuticals for approximately $3.85 billion.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">[29]</a></sup> In December 2014 Merck &amp; Co. announced they would be spending $8.4 billion to buy <a href="/wiki/Cubist_Pharmaceuticals" title="Cubist Pharmaceuticals">Cubist Pharmaceuticals</a>.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">[30]</a></sup> Later in the same month the company acquired the Swiss biotechnology company OncoEthix for up to $375 million dependent upon certain milestone achievements.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31">[31]</a></sup></p><p>In July 2015 Merck &amp; Co. and <a href="/wiki/Ablynx" title="Ablynx">Ablynx</a> expanded their 18 month old immuno-oncology collaboration by four years, generating a potential $4.4 billion in milestone payments for the Abylnx.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32">[32]</a></sup> Days later Merck &amp; Co. announced it would spend $95 million up front on collaborating with cCAM Biotherapeutics and its lead candidate (an early-stage treatment similar to Keytruda). The company is due up to $510 million more, which is tied to clinical, regulatory and commercial milestones. Merck &amp; Co. will bring in CM-24, an antibody designed to block the immune checkpoint <a href="/wiki/CEACAM1" title="CEACAM1">CEACAM1</a>.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33">[33]</a></sup></p><p>In January 2016 Merck &amp; Co. announced two new partnerships; the first with Quartet Medicine and its small molecule pain treatments,<sup id="cite_ref-34" class="reference"><a href="#cite_note-34">[34]</a></sup> the second with Complix investigating intracellular cancer targets,<sup id="cite_ref-35" class="reference"><a href="#cite_note-35">[35]</a></sup> with both collaborations potentially generating up to $595 million and $280 million respectively. Days later the company announced it would acquire IOmet Pharma, with IOmet becoming a wholly owned subsidiary of Merck &amp; Co. The acquisition includes IOmets <a href="/wiki/Indoleamine-2,3-dioxygenase_1" class="mw-redirect" title="Indoleamine-2,3-dioxygenase 1">indoleamine-2,3-dioxygenase 1</a> (IDO), <a href="/wiki/Tryptophan_2,3-dioxygenase" title="Tryptophan 2,3-dioxygenase">tryptophan 2,3-dioxygenase</a> (TDO), and dual-acting inhibitors.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">[36]</a></sup> In June, the company announced its acquisition of Afferent Pharmaceuticals for $1.25 billion, gaining Afferents lead compound—AF-219—used to block <a href="/wiki/P2RX3" title="P2RX3">P2X3 receptors</a>.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">[37]</a></sup></p><p>In April 2017, Merck Animal Health acquired Brazilian animal health product manufacturer, Vallée S.A.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38">[38]</a></sup> In September, the company announced it would acquire Rigontec for $554 million, acquiring Rigontec's lead compound <a href="/w/index.php?title=RGT100&amp;action=edit&amp;redlink=1" class="new" title="RGT100 (page does not exist)">RGT100</a>, which targets the <a href="/wiki/Retinoic_acid-inducible_gene_I" class="mw-redirect" title="Retinoic acid-inducible gene I">retinoic acid-inducible gene I</a> pathway.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39">[39]</a></sup></p><p>In February 2018, Merck announced it would acquire Australian viral cancer drug company, <a href="/wiki/Viralytics" title="Viralytics">Viralytics</a> for AUD$502 million ($394 million), boosting Merck's own pipeline.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">[40]</a></sup> In December, the company announced it would acquire Antelliq Group for $2.4 billion ($3.7 billion including debt).<sup id="cite_ref-41" class="reference"><a href="#cite_note-41">[41]</a></sup></p><p>In February 2019, the company announced its acquisition of Immune Design Corp for nearly $300 million ($5.85 in cash per share), gaining access to its immunotherapy programs.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42">[42]</a></sup><sup id="cite_ref-43" class="reference"><a href="#cite_note-43">[43]</a></sup> In May, Merck announced it would acquire Peloton Therapeutics for up to $2.2 billion, boosting its oncology pipeline through the acquisition of Pelotons lead drug, PT2977, a HIF-2alpha inhibitor currently in a Phase II trials for <a href="/wiki/Von_Hippel-Lindau_disease" class="mw-redirect" title="Von Hippel-Lindau disease">von Hippel-Lindau disease</a>-associated <a href="/wiki/Renal_cell_carcinoma" title="Renal cell carcinoma">renal cell carcinoma</a>.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44">[44]</a></sup> In June Merck announced it would also acquire Tilos Therapeutics for up to $773 million.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45">[45]</a></sup> In November the company acquired Calporta, which focus on Parkinsons and Alzheimers treatments.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46">[46]</a></sup> In December Merck announced it would acquire ArQule, Inc., for $20 per share, $2.7 billion in total and its lead compound: ARQ 531, an oral <a href="/wiki/Bruton%27s_tyrosine_kinase" title="Bruton's tyrosine kinase">Bruton’s tyrosine kinase</a> (BTK) inhibitor.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47">[47]</a></sup><sup id="cite_ref-48" class="reference"><a href="#cite_note-48">[48]</a></sup> In the same month, the animal health division of the business announced it would acquire aquaculture company, Vaki, from <a href="/wiki/Pentair" title="Pentair">Pentair</a>.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49">[49]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="2020_to_Present">2020 to Present</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=6" title="Edit section: 2020 to Present" data-section="6" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>On 5 February 2020 Merck announced the formation of a new, independent publicly traded company focused on its Women’s Health, trusted Legacy Brands, and Biosimilars businesse. Carrie Cox will be named Chairman of the Board of Directors. Cox formerly served as chair of <a href="/wiki/Array_BioPharma" title="Array BioPharma">Array BioPharma, Inc</a>., CEO and chair of Humacyte, Inc., president of Global Pharmaceuticals at <a href="/wiki/Schering-Plough" title="Schering-Plough">Schering-Plough Corporation</a>, executive vice president of <a href="/wiki/Pharmacia" title="Pharmacia">Pharmacias Corporation</a> and vice president of Women's Health Care at <a href="/wiki/Wyeth" title="Wyeth">Wyeth-Ayerst Laboratories, Inc.</a><sup id="cite_ref-50" class="reference"><a href="#cite_note-50">[50]</a></sup></p><p>In March 2020, Merck &amp; Co. was one of ten companies recognized at the inaugural Manufacturing Awards by <a href="/wiki/New_Jersey_Business_magazine" title="New Jersey Business magazine">New Jersey Business magazine</a> and the <a href="/wiki/New_Jersey_Business_and_Industry_Association" title="New Jersey Business and Industry Association">New Jersey Business &amp; Industry Association</a>.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51">[51]</a></sup></p>
<h3 class="in-block"><span id=".22Merck.22_name_legal_dispute"></span><span class="mw-headline" id='"Merck"_name_legal_dispute'>"Merck" name legal dispute</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=7" title='Edit section: "Merck" name legal dispute' data-section="7" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 191 of 193 countries, the original Merck company, the <a href="/wiki/Merck_Group" title="Merck Group">Merck Group</a> of Darmstadt, owns the rights to the "Merck" name. In the United States and Canada, the company trades under the name EMD (an abbreviation of Emanuel Merck, Darmstadt). In the United States and Canada, Merck &amp; Co. holds the rights to the trademark "Merck", while in the rest of the world the company trades under the name MSD (an abbreviation of Merck, Sharp &amp; Dohme).
</p><p>In 2015 the <a href="/wiki/Merck_Group" title="Merck Group">Merck Group</a> adopted a new logo and said it will be "much more aggressive" about protecting the brand of "the real Merck".<sup id="cite_ref-Bloomberg14_52-0" class="reference"><a href="#cite_note-Bloomberg14-52">[52]</a></sup> Merck of Darmstadt has initiated litigation against its former subsidiary, Merck &amp; Co. (MSD) of Kenilworth, in several countries over infringing use of the Merck name. In 2016, the <a href="/wiki/High_Court_of_Justice" title="High Court of Justice">High Court of Justice</a> in the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a> ruled that MSD had breached an agreement with its former parent company and that only Merck of Darmstadt is entitled to use the Merck name in the United Kingdom.<sup id="cite_ref-:3_14-1" class="reference"><a href="#cite_note-:3-14">[14]</a></sup> The judge also held that MSD's use of "Merck" as part of branding on its global websites were directed to the UK and infringed Merck's trade mark rights in the UK.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53">[53]</a></sup></p><p>In response to the ruling, MSD initiated counter-litigation in the United States in January 2016 by filing a federal lawsuit which accused its former parent company of "infringing on its trademark" through actions that included the increased usage of “Merck KGaA” and “MERCK” in branding in the US as well as on its social media presence. Further Merck &amp; Co. has also accused the Merck Group of federal trademark dilution, unfair competition, false advertising, deceptive trade practices, breach of contract, and <a href="/wiki/Cybersquatting" title="Cybersquatting">cybersquatting</a>. The case came to a head when a research scientist believed he was communicating with Merck &amp; Co regarding a research grant in oncology, when in fact they were talking with the Merck Group. As a result, Merck &amp; Co. asked the federal court to stop the Merck Group from using “Merck” on any products or marketing materials in the United States. As a direct result, Merck &amp; Co is seeking “<i>all monetary gains, profits, and advantages</i>” made by the Merck Group and three-times the damage, plus additional punitive damages.<sup id="cite_ref-genengnews.com_11-1" class="reference"><a href="#cite_note-genengnews.com-11">[11]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(2)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Acquisition_history">Acquisition history</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=8" title="Edit section: Acquisition history" data-section="8" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-2 collapsible-block" id="mf-section-2">
<div class="mw-collapsible mw-collapsed" style="box-sizing:border-box;width:100%;font-size:95%;padding:4px;border:1px #aaa solid;"><div style="font-size:100%;line-height:1.6;font-weight:bold;background:transparent;text-align:center;;">Merck &amp; Co Acquisitions</div><div class="mw-collapsible-content" style="background:transparent;text-align:left;;">
<style data-mw-deduplicate="TemplateStyles:r886050385">.mw-parser-output .treeview ul{padding:0;margin:0}.mw-parser-output .treeview li{padding:0;margin:0;list-style-type:none;list-style-image:none}.mw-parser-output .treeview li li{background:url("//upload.wikimedia.org/wikipedia/commons/f/f2/Treeview-grey-line.png")no-repeat 0 -2981px;padding-left:21px;text-indent:0.3em}.mw-parser-output .treeview li li:last-child{background-position:0 -5971px}.mw-parser-output .treeview li.emptyline>ul>.mw-empty-elt:first-child+.emptyline,.mw-parser-output .treeview li.emptyline>ul>li:first-child{background-position:0 9px}</style><div class="treeview">
<ul><li><b>Merck &amp; Co</b> <small>(Founded in 1891 as the US subsidiary of <a href="/wiki/Merck_Group" title="Merck Group">Merck of Darmstadt</a>, later Nationalized by the US government in 1917 during the first World War)</small>
<ul><li>Merck &amp; Co
<ul><li>H. K. Mulford Company <small>(Acq 1929)</small></li>
<li>Sharp &amp; Dohme, Inc <small>(Acq 1953)</small></li>
<li>Charles E. Frosst Ltd <small>(Acq 1965, restructured into Merck-Frosst Canada, Inc, restructured into Merck Canada in 2011)</small></li>
<li>Medco Containment Services Inc <small>(Acq 1993, Spun off 2003)</small></li></ul></li>
<li>Schering‑Plough
<ul><li><a href="/wiki/Schering-Plough" title="Schering-Plough">Schering-Plough</a> <small>(Merged 1971)</small>
<ul><li>Schering Corporation <small>(Founded 1851)</small></li>
<li>Plough, Inc <small>(Founded 1908)</small></li></ul></li>
<li>Organon International</li>
<li>Intervet</li>
<li>Diosynth</li>
<li>Nobilon</li></ul></li>
<li>Imperial Blue Corporation<sup id="cite_ref-54" class="reference"><a href="#cite_note-54">[54]</a></sup><ul><li>Idenix Pharmaceuticals <small>(Acq 2014)</small></li></ul></li>
<li>Maven Corporation<sup id="cite_ref-55" class="reference"><a href="#cite_note-55">[55]</a></sup><ul><li><a href="/wiki/Cubist_Pharmaceuticals" title="Cubist Pharmaceuticals">Cubist Pharmaceuticals</a>
<ul><li><a href="/wiki/Trius_Therapeutics" title="Trius Therapeutics">Trius Therapeutics</a> <small>(Acq 2013)</small></li>
<li>Optimer Pharmaceuticals <small>(Acq 2013)</small></li></ul></li></ul></li>
<li>OncoEthix <small>(Acq 2015)</small></li>
<li>IOmet Pharma <small>(Acq 2016)</small></li>
<li>Afferent Pharmaceuticals <small>(Acq 2016)</small></li>
<li>Merck Animal Health
<ul><li>Vallée S.A. <small>(Acq 2017)</small></li>
<li>Vaki <small>(Acq 2019)</small></li></ul></li>
<li>Rigontec <small>(Acq 2017)</small></li>
<li>Viralytics <small>(Acq 2018)</small></li>
<li>Antelliq Group <small>(Acq 2018)</small></li>
<li>Cascade Merger Sub, Inc.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56">[56]</a></sup><ul><li>Immune Design Corp <small>(Acq 2019)</small></li></ul></li>
<li>Peloton Therapeutics <small>(Acq 2019)</small></li>
<li>Tilos Therapeutics <small>(Acq 2019)</small></li>
<li>Calporta <small>(Acq 2019)</small></li>
<li>Argon Merger Sub, Inc.
<ul><li>ArQule, Inc. <small>(Acq 2019)</small></li></ul></li></ul></li></ul></div>
</div></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(3)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Corporate_governance">Corporate governance</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=9" title="Edit section: Corporate governance" data-section="9" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-3 collapsible-block" id="mf-section-3">
<p>In 2005, <a href="/wiki/Chief_executive_officer" title="Chief executive officer">CEO</a> <a href="/wiki/Raymond_Gilmartin" title="Raymond Gilmartin">Raymond Gilmartin</a> retired following Merck's voluntary worldwide withdrawal of <a href="/wiki/Vioxx" class="mw-redirect" title="Vioxx">Vioxx</a>. Former president of manufacturing <a href="/wiki/Richard_Clark_(pharmacologist)" class="mw-redirect" title="Richard Clark (pharmacologist)">Richard Clark</a> was named CEO and company president. Clark retired in October 2011 and <a href="/wiki/Kenneth_Frazier" title="Kenneth Frazier">Kenneth Frazier</a> became CEO.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57">[57]</a></sup></p><p>On April 23, 2014, Robert M. Davis, formerly CFO of <a href="/wiki/Baxter_International" title="Baxter International">Baxter International</a>, became Merck's <a href="/wiki/Chief_financial_officer" title="Chief financial officer">CFO</a>.<sup id="cite_ref-apmerckcfo2014_58-0" class="reference"><a href="#cite_note-apmerckcfo2014-58">[58]</a></sup>  Davis replaced Peter N. Kellogg, who held the post from 2007.<sup id="cite_ref-apmerckcfo2014_58-1" class="reference"><a href="#cite_note-apmerckcfo2014-58">[58]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(4)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Products">Products</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=10" title="Edit section: Products" data-section="10" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-4 collapsible-block" id="mf-section-4">
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:HPV-vaccine-_Gardasil2016JAPAN-03.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/37/HPV-vaccine-_Gardasil2016JAPAN-03.jpg/220px-HPV-vaccine-_Gardasil2016JAPAN-03.jpg" decoding="async" width="220" height="165" class="thumbimage" data-file-width="3264" data-file-height="2448"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 165px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/3/37/HPV-vaccine-_Gardasil2016JAPAN-03.jpg/220px-HPV-vaccine-_Gardasil2016JAPAN-03.jpg" data-alt="" data-width="220" data-height="165" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:HPV-vaccine-_Gardasil2016JAPAN-03.jpg" class="internal" title="Enlarge"></a></div>Gardasil in Japanese packaging (showing the MSD branding)</div></div></div>
<h3 class="in-block"><span class="mw-headline" id="Current">Current</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=11" title="Edit section: Current" data-section="11" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>As of August 2014, Merck's research and development effort has led to the approval of more new drugs than that of any other company. Research performed at Merck has led to U.S. FDA approval of 63 <a href="/wiki/New_molecular_entity" class="mw-redirect" title="New molecular entity">New Molecular Entities</a>.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59">[59]</a></sup> In 2014, Merck's major products included<sup id="cite_ref-60" class="reference"><a href="#cite_note-60">[60]</a></sup></p>
<ul><li><a href="/wiki/Januvia" class="mw-redirect" title="Januvia">Januvia</a> (sitagliptin), a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. In 2013, Januvia was the second largest selling diabetes drug worldwide,<sup id="cite_ref-61" class="reference"><a href="#cite_note-61">[61]</a></sup> with $4.0 billion in worldwide sales. Januvia is commonly paired with the generic anti-diabetes drug <a href="/wiki/Metformin" title="Metformin">metformin</a>. It has been popular due in part because unlike many other diabetes drugs, it causes little or no weight gain and is not associated with hypoglycemic episodes.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62">[62]</a></sup><sup id="cite_ref-63" class="reference"><a href="#cite_note-63">[63]</a></sup> Merck also sells a single pill combination drug containing both Januvia and metformin under the trade name Janumet. There has been some concern that treatment with Januvia and other DPP-IV inhibitors may be associated with a modestly increased risk of pancreatitis.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64">[64]</a></sup></li>
<li><a href="/wiki/Zetia" class="mw-redirect" title="Zetia">Zetia</a> (ezetimibe) is a drug for hypercholesterolemia that acts by inhibiting the absorption of dietary cholesterol. Sales in 2013 amounted to $2.7 billion. Zetia has been controversial, as it was initially approved based on its impact on serum cholesterol levels without proof that it actually impacted the incidence of cardiovascular disease. Results of the IMPROVE-IT study, however, introduced at the 2014 Scientific Sessions of the American Heart Association, showed a statistically significant, albeit modest, benefit in adding Zetia to simvastatin for high-risk, post-acute-coronary-syndrome patients.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65">[65]</a></sup></li>
<li><a href="/wiki/Remicade" class="mw-redirect" title="Remicade">Remicade</a> (infliximab) is a monoclonal antibody directed toward the cytokine <a href="/wiki/TNF-alpha" class="mw-redirect" title="TNF-alpha">TNF-alpha</a> and used for the treatment of a wide range of autoimmune disorders, including <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a>, <a href="/wiki/Crohn%27s_disease" title="Crohn's disease">Crohn's disease</a>, <a href="/wiki/Ankylosing_spondylitis" title="Ankylosing spondylitis">ankylosing spondylitis</a>, <a href="/wiki/Plaque_psoriasis" class="mw-redirect" title="Plaque psoriasis">plaque psoriasis</a>, and others. Remicade and other TNF-alpha inhibitors exhibit additive therapeutic effects with methotrexate and improve quality of life. Adverse effects include increased risk of infection and certain cancers.<sup id="cite_ref-66" class="reference"><a href="#cite_note-66">[66]</a></sup> Merck had rights to the drug in certain areas, while <a href="/wiki/Janssen_Biotech" title="Janssen Biotech">Janssen Biotech</a> had rights in other areas;<sup id="cite_ref-67" class="reference"><a href="#cite_note-67">[67]</a></sup> in 2017, Merck announced a biosimilar to Remicade, Renflexis.<sup id="cite_ref-68" class="reference"><a href="#cite_note-68">[68]</a></sup></li>
<li><a href="/wiki/Gardasil" title="Gardasil">Gardasil</a> (recombinant human papilloma virus vaccine) is a vaccine against multiple serotypes of <a href="/wiki/Human_papillomavirus" class="mw-redirect" title="Human papillomavirus">human papilloma virus</a> (HPV), which is responsible for most cases of cervical cancer worldwide.<sup id="cite_ref-69" class="reference"><a href="#cite_note-69">[69]</a></sup></li>
<li><a href="/wiki/Isentress" class="mw-redirect" title="Isentress">Isentress</a> (raltegravir) is a human immunodeficiency virus integrase inhibitor for the treatment of HIV infection. It is the first anti-HIV compound having this mechanism of action.<sup id="cite_ref-70" class="reference"><a href="#cite_note-70">[70]</a></sup> Sales in 2013 were $1.8 billion. It is part of one of several first line treatment regimens recommended by the United States Department of Health and Human Services.<sup id="cite_ref-71" class="reference"><a href="#cite_note-71">[71]</a></sup></li>
<li><a href="/wiki/Keytruda" class="mw-redirect" title="Keytruda">Keytruda</a> (pembrolizumab) is an immune modulator for the treatment of cancer. On September 4, 2014, the US Food and Drug Administration (FDA) approved <a href="/wiki/Pembrolizumab" title="Pembrolizumab">Pembrolizumab</a> (MK-3475) as a breakthrough therapy for melanoma treatment.<sup id="cite_ref-72" class="reference"><a href="#cite_note-72">[72]</a></sup> In clinical trials, pembrolzumab provided partial tumor regression in about one quarter of patients, many of whom have not seen further progression of their disease in over 6 months of follow-up.<sup id="cite_ref-73" class="reference"><a href="#cite_note-73">[73]</a></sup></li>
<li>Invanz (<a href="/wiki/Ertapenem" title="Ertapenem">Ertapenem</a>) is an injectable antibiotic, rights to which Merck has owned since 1999.<sup id="cite_ref-:0_24-1" class="reference"><a href="#cite_note-:0-24">[24]</a></sup> As of 2015, Merck was in a legal dispute with the Taiwanese company Savior Lifetec over their attempt to secure rights to sell a <a href="/wiki/Generic_drug" title="Generic drug">generic version of this drug</a> in the United States.<sup id="cite_ref-:0_24-2" class="reference"><a href="#cite_note-:0-24">[24]</a></sup></li></ul><p>In 2018, Merck began the submission process for a Biologics License Application to the U.S. Food and Drug Administration (FDA). The application was for an investigational vaccine, called V920, to fight the Zaire strain of the Ebola virus. V920 "falls under the FDA’s Breakthrough Therapy Designation. It is intended to expedite the development of a candidate that can treat a serious or life-threatening condition when preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies . . ."<sup id="cite_ref-74" class="reference"><a href="#cite_note-74">[74]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Other_products">Other products</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=12" title="Edit section: Other products" data-section="12" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<ul><li><a href="/wiki/Mexsana" title="Mexsana">Mexsana</a>, an antiseptic medicated powder</li></ul><h3 class="in-block"><span class="mw-headline" id="Legacy_products">Legacy products</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=13" title="Edit section: Legacy products" data-section="13" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<h4 class="in-block"><span class="mw-headline" id="Vaccines">Vaccines</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=14" title="Edit section: Vaccines" data-section="14" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p>Medically important vaccines developed at Merck include the first <a href="/wiki/Mumps_vaccine" title="Mumps vaccine">mumps vaccine</a>,<sup id="cite_ref-75" class="reference"><a href="#cite_note-75">[75]</a></sup> the first <a href="/wiki/Rubella_vaccine" title="Rubella vaccine">rubella vaccine</a>,<sup id="cite_ref-76" class="reference"><a href="#cite_note-76">[76]</a></sup> and the first trivalent measles, mumps, rubella (<a href="/wiki/MMR_vaccine" title="MMR vaccine">MMR vaccine</a>),<sup id="cite_ref-77" class="reference"><a href="#cite_note-77">[77]</a></sup> each of which was developed by Merck scientist <a href="/wiki/Maurice_Hilleman" title="Maurice Hilleman">Maurice Hilleman</a>. The incidence of rubella-associated birth defects fell from up to 10,000 per year in the U.S. to zero in the aftermath of the rubella vaccine's development.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78">[78]</a></sup> Hilleman also developed the first <a href="/wiki/Hepatitis_B_vaccine" title="Hepatitis B vaccine">Hepatitis B vaccine</a><sup id="cite_ref-79" class="reference"><a href="#cite_note-79">[79]</a></sup> and the first <a href="/wiki/Varicella_vaccine" title="Varicella vaccine">varicella vaccine</a>, for chickenpox.<sup id="cite_ref-80" class="reference"><a href="#cite_note-80">[80]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Thiazide_anti-hypertensives">Thiazide anti-hypertensives</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=15" title="Edit section: Thiazide anti-hypertensives" data-section="15" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p>The thiazide diuretics were developed by scientists Karl H. Beyer, James M. Sprague, John E. Baer, and Frederick C. Novello of <a href="/wiki/Merck_and_Co." class="mw-redirect" title="Merck and Co.">Merck and Co.</a> in the 1950s,<sup id="cite_ref-81" class="reference"><a href="#cite_note-81">[81]</a></sup> and led to the marketing of the first drug of this class, <a href="/wiki/Chlorothiazide" title="Chlorothiazide">chlorothiazide</a>, under the trade name Duiril in 1958.<sup id="cite_ref-82" class="reference"><a href="#cite_note-82">[82]</a></sup> The research leading to the discovery of chlorothiazide, leading to "the saving of untold thousands of lives and the alleviation of the suffering of millions of victims of hypertension" was recognized by a special Public Health Award from the Lasker Foundation in 1975.<sup id="cite_ref-83" class="reference"><a href="#cite_note-83">[83]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="First_statin">First statin</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=16" title="Edit section: First statin" data-section="16" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p>Merck scientists also developed <a href="/wiki/Lovastatin" title="Lovastatin">lovastatin</a>, the first drug of the <a href="/wiki/Statin" title="Statin">statin</a> class.<sup id="cite_ref-84" class="reference"><a href="#cite_note-84">[84]</a></sup> It was marketed under the trade name Mevacor.
</p>
<h4 class="in-block"><span class="mw-headline" id="Antibacterials">Antibacterials</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=17" title="Edit section: Antibacterials" data-section="17" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p>Streptomycin, discovered during a Merck-funded research program in Selman Waksman's laboratory at <a href="/wiki/Rutgers_University" title="Rutgers University">Rutgers University</a> in 1943, became the first effective treatment for tuberculosis. At the time of its discovery, sanitoriums for the isolation of tuberculosis-infected people were a ubiquitous feature of cities in developed countries, with 50% dying within 5 years of admission.<sup id="cite_ref-85" class="reference"><a href="#cite_note-85">[85]</a></sup><sup id="cite_ref-86" class="reference"><a href="#cite_note-86">[86]</a></sup> Although Merck's agreement with Rutgers gave it exclusive rights to streptomycin, at Wakman's request the company renegotiated the agreement, returning the rights to the university in exchange for a royalty. The university then set up non-exclusive licenses with seven companies to ensure a reliable supply of the antibiotic.<sup id="cite_ref-87" class="reference"><a href="#cite_note-87">[87]</a></sup></p><p>In 1985 Merck received approval for <a href="/wiki/Imipenem" title="Imipenem">imipenem</a>, the first member of the <a href="/wiki/Carbapenem" title="Carbapenem">carbapenem</a> class of antibiotics. Antibiotics of the carbapenem class play an important role in treatment guidelines for certain hospital-acquired and multi-drug resistant infections.<sup id="cite_ref-88" class="reference"><a href="#cite_note-88">[88]</a></sup><sup id="cite_ref-89" class="reference"><a href="#cite_note-89">[89]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Vioxx">Vioxx</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=18" title="Edit section: Vioxx" data-section="18" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p>In 1999, the <a href="/wiki/Food_and_Drug_Administration_(United_States)" class="mw-redirect" title="Food and Drug Administration (United States)">U.S. Food and Drug Administration</a> (FDA) approved Vioxx (known generically as <a href="/wiki/Rofecoxib" title="Rofecoxib">rofecoxib</a>), a Merck product for treating <a href="/wiki/Arthritis" title="Arthritis">arthritis</a>. Vioxx was designed as a selective inhibitor of the enzyme <a href="/wiki/Cyclooxygenase-2" class="mw-redirect" title="Cyclooxygenase-2">cyclooxygenase-2</a>. Such compounds were expected to cause less gastrointestinal bleeding than older <a href="/wiki/Anti-inflammatory" title="Anti-inflammatory">anti-inflammatory</a> drugs such as <a href="/wiki/Naproxen" title="Naproxen">naproxen</a>, which were associated with 20,000 hospitalizations and 2000 deaths each year.<sup id="cite_ref-90" class="reference"><a href="#cite_note-90">[90]</a></sup><sup class="noprint Inline-Template noprint Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:No_original_research#Primary,_secondary_and_tertiary_sources" title="Wikipedia:No original research"><span title="This claim needs references to reliable secondary sources. (November 2015)">non-primary source needed</span></a></i>]</sup> Vioxx became one of the most prescribed drugs in history.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>]</sup></p><p>Thereafter, studies by Merck and by others found an increased risk of heart attack associated with <a href="/wiki/Vioxx" class="mw-redirect" title="Vioxx">Vioxx</a> use when compared with naproxen. Merck adjusted the labeling of Vioxx to reflect possible cardiovascular risks in 2002.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>]</sup></p><p>On September 23, 2004, Merck received information about results from a <a href="/wiki/Clinical_trial" title="Clinical trial">clinical trial</a> it was conducting that included findings of increased risk of heart attacks among Vioxx users who had been using the medication for over eighteen months.<sup id="cite_ref-91" class="reference"><a href="#cite_note-91">[91]</a></sup> On September 28, 2004, Merck notified the FDA that it was voluntarily withdrawing Vioxx from the market, and it publicly announced the withdrawal on September 30. An analysis for the period 1999-2004, based on U.S. Medical Expenditure Survey data, reported that Vioxx was associated with 46,783 heart attacks, and along with the other popular <a href="/wiki/COX-2_inhibitor" title="COX-2 inhibitor">COX-2 inhibitor</a> <a href="/wiki/Celebrex" class="mw-redirect" title="Celebrex">Celebrex</a>, an estimated 26,603 deaths from both.<sup id="cite_ref-92" class="reference"><a href="#cite_note-92">[92]</a></sup><sup class="noprint Inline-Template noprint Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:No_original_research#Primary,_secondary_and_tertiary_sources" title="Wikipedia:No original research"><span title="This claim needs references to reliable secondary sources. (November 2015)">non-primary source needed</span></a></i>]</sup></p><p>About 50,000 people sued Merck, claiming they or their family members had suffered medical problems such as heart attacks or strokes after taking Vioxx.<sup id="cite_ref-NYT_93-0" class="reference"><a href="#cite_note-NYT-93">[93]</a></sup> In November 2007, Merck agreed to pay $4.85 billion to settle most of the pending Vioxx lawsuits.<sup id="cite_ref-NYT2_94-0" class="reference"><a href="#cite_note-NYT2-94">[94]</a></sup> The settlement required that claimants provide medical and pharmacy records confirming the occurrence of a heart attack, ischemic stroke, or sudden cardiac death; the receipt of at least 30 Vioxx pills within 60 days prior to the injury or death; and confirmation of Vioxx being used within 14 days of the Vioxx-related event.<sup id="cite_ref-95" class="reference"><a href="#cite_note-95">[95]</a></sup> The settlement was generally viewed by industry analysts and investors as a victory for Merck, considering that original estimates of Merck's liability reached between $10 billion and $25 billion.<sup id="cite_ref-NYT2_94-1" class="reference"><a href="#cite_note-NYT2-94">[94]</a></sup> In fact, as of mid-2008, when the plaintiff class had reached the threshold percentage required by Merck to go through with the settlement, plaintiffs had prevailed in only three of the twenty cases that had reached juries, all with relatively small awards.<sup id="cite_ref-NYT_93-1" class="reference"><a href="#cite_note-NYT-93">[93]</a></sup></p><p>Merck has refused to consider compensation for Vioxx victims and their families outside the US. This is particularly true in the UK where there are at least 400 victims and the legal protection afforded to the victims and their families is particularly weak.<sup id="cite_ref-96" class="reference"><a href="#cite_note-96">[96]</a></sup></p><p>According to internal e-mail traffic released at a later lawsuit, Merck had a list of doctors critical of Vioxx to be "neutralized" or "discredited". "We may need to seek them out and destroy them where they live," wrote an employee. A Stanford Medical School professor said that Merck was engaged in intimidation of researchers and infringement upon <a href="/wiki/Academic_freedom" title="Academic freedom">academic freedom</a>.<sup id="cite_ref-97" class="reference"><a href="#cite_note-97">[97]</a></sup></p><p>On May 20, 2008, Merck settled for $58 million with 30 states alleging that Merck engaged in deceptive marketing tactics to promote <a href="/wiki/Vioxx" class="mw-redirect" title="Vioxx">Vioxx</a>.<sup id="cite_ref-98" class="reference"><a href="#cite_note-98">[98]</a></sup> All its new television pain-advertisements must be vetted by the Food and Drug Administration and changed or delayed upon request until 2018.<sup id="cite_ref-99" class="reference"><a href="#cite_note-99">[99]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Mectizan">Mectizan</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=19" title="Edit section: Mectizan" data-section="19" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p>In 1987, Merck &amp; Co. began a program with <a href="/wiki/UNICEF" title="UNICEF">UNICEF</a> to donate its new drug <a href="/wiki/Mectizan" class="mw-redirect" title="Mectizan">Mectizan</a> to "all that need it for as long as needed"<sup id="cite_ref-100" class="reference"><a href="#cite_note-100">[100]</a></sup> in an effort to combat <a href="/wiki/Onchocerciasis" title="Onchocerciasis">onchocerciasis</a>, also known as river blindness, primarily in Africa. Up to that point, the <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> had fought the disease through the use of insecticides to lower the population of its primary vector, the <a href="/wiki/Black_Fly" class="mw-redirect" title="Black Fly">Black Fly</a>.<sup id="cite_ref-101" class="reference"><a href="#cite_note-101">[101]</a></sup> However, when studies in the 1980s showed how effective the drug was at treating and preventing the disease, the WHO agreed to use it instead of its previous strategies. Merck's involvement is considered a key factor in the success against the disease all over the world,<sup id="cite_ref-102" class="reference"><a href="#cite_note-102">[102]</a></sup> and the decision to donate the entirety of the drug to all those in need of it is used as part of the Mectizan Donation Program that covers countries such as Yemen and African countries.<sup id="cite_ref-Mectizan_Donation_Program_103-0" class="reference"><a href="#cite_note-Mectizan_Donation_Program-103">[103]</a></sup></p><p>More than 700 million people have been treated since the inception of the program with 80 million people still undergoing treatment in Africa, Latin America, and Yemen. Blindness caused by onchocerciasis is decreasing, and there are regions of Latin America and Africa that have been shown to have completely eliminated the disease altogether.<sup id="cite_ref-Mectizan_Donation_Program_103-1" class="reference"><a href="#cite_note-Mectizan_Donation_Program-103">[103]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Fosamax">Fosamax</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=20" title="Edit section: Fosamax" data-section="20" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p>Fosamax (<a href="/wiki/Alendronate" class="mw-redirect" title="Alendronate">alendronate</a>) is a <a href="/wiki/Bisphosphonate" title="Bisphosphonate">bisphosphonate</a> used for the treatment of post-menopausal osteoporosis and for the prevention of skeletal problems in certain cancers. The American College of Clinical Endocrinology, the American College of Obstetricians and Gynecologists, the North American Menopause Society and the UK National Osteoporosis Guideline Group recommend alendronate and certain other bisphosphonates as first line treatments for post-menopausal osteopotosis.<sup id="cite_ref-104" class="reference"><a href="#cite_note-104">[104]</a></sup><sup id="cite_ref-105" class="reference"><a href="#cite_note-105">[105]</a></sup><sup id="cite_ref-106" class="reference"><a href="#cite_note-106">[106]</a></sup><sup id="cite_ref-107" class="reference"><a href="#cite_note-107">[107]</a></sup>
Long-term treatment with bisphosponates produces anti-fracture and bone mineral density effects that persist for 3–5 years after an initial 3–5 years of treatment.<sup id="cite_ref-108" class="reference"><a href="#cite_note-108">[108]</a></sup> Alendronate reduces the risk of hip, vertebral, and wrist fractures by 35-39%.<sup id="cite_ref-109" class="reference"><a href="#cite_note-109">[109]</a></sup><sup id="cite_ref-110" class="reference"><a href="#cite_note-110">[110]</a></sup></p><p>In December 2013, Merck agreed to pay a total of $27.7 million to 1,200 plaintiffs in a class action lawsuit alleging that the company's osteoporosis drug had caused them to develop osteonecrosis of the jaw. Prior to the settlement, Merck had prevailed in 3 of 5 so-called bellwether trials. Approximately 4000 cases still await adjudiction or settlement as of August 2014.<sup id="cite_ref-111" class="reference"><a href="#cite_note-111">[111]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(5)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Society_and_culture">Society and culture</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=21" title="Edit section: Society and culture" data-section="21" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-5 collapsible-block" id="mf-section-5">
<h3 class="in-block"><span class="mw-headline" id="Patient_assistance_programs">Patient assistance programs</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=22" title="Edit section: Patient assistance programs" data-section="22" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Merck &amp; Co. was one of the first American pharmaceutical companies to offer assistance to those unable to afford its medications, beginning a program in the 1950s.<sup id="cite_ref-112" class="reference"><a href="#cite_note-112">[112]</a></sup> Merck &amp; Co. offers seven patient assistance programs, each with specific eligibility requirements.<sup id="cite_ref-113" class="reference"><a href="#cite_note-113">[113]</a></sup><sup id="cite_ref-114" class="reference"><a href="#cite_note-114">[114]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Restructurings">Restructurings</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=23" title="Edit section: Restructurings" data-section="23" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Following the merger with Schering Plough in 2009, Merck started laying off workers, cutting around 36,450 jobs between 2010 and 2015.<sup id="cite_ref-Fierce2015_115-0" class="reference"><a href="#cite_note-Fierce2015-115">[115]</a></sup> During that time the company sold its consumer health business to Bayer and narrowed the company's focus to immunology, vaccines, diabetes, emerging markets and medicines used in hospitals, like certain antibiotics.<sup id="cite_ref-Fierce2015_115-1" class="reference"><a href="#cite_note-Fierce2015-115">[115]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Sham_medical_journal">Sham medical journal</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=24" title="Edit section: Sham medical journal" data-section="24" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>From 2002 through 2005 the Australian affiliate of Merck paid <a href="/wiki/Elsevier" title="Elsevier">Elsevier</a> an undisclosed amount to publish eight issues of a medical journal, the <i><a href="/wiki/Australasian_Journal_of_Bone_and_Joint_Medicine" class="mw-redirect" title="Australasian Journal of Bone and Joint Medicine">Australasian Journal of Bone and Joint Medicine</a></i>. Although it gave the appearance of being an independent peer-reviewed journal, without any indication that Merck had paid for it, the journal actually reprinted articles that originally appeared in other publications and that were favorable to Merck. The misleading publication came to light in 2009 during a personal injury lawsuit filed over Vioxx; 9 of 29 articles in the journal's second issue referred positively to Vioxx.<sup id="cite_ref-116" class="reference"><a href="#cite_note-116">[116]</a></sup> In 2009, the CEO of Elsevier's Health Sciences Division, Michael Hansen, admitted that the practice was "unacceptable".<sup id="cite_ref-117" class="reference"><a href="#cite_note-117">[117]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Hilleman_Laboratories">Hilleman Laboratories</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=25" title="Edit section: Hilleman Laboratories" data-section="25" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Merck and the Wellcome trust jointly fund the <a href="/wiki/Hilleman_Laboratories" title="Hilleman Laboratories">Hilleman Laboratories</a>, an India-based non-profit research organization dedicated to the development of low-cost vaccines for use in developing countries. Current projects include the development of low cost, thermostable vaccines for the prevention of cholera, rotavirus, and meningitis.<sup id="cite_ref-118" class="reference"><a href="#cite_note-118">[118]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Medicaid_overbilling">Medicaid overbilling</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=26" title="Edit section: Medicaid overbilling" data-section="26" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>A US Justice Department fraud investigation began in 2000 when allegations were brought in two separate lawsuits filed by whistleblowers under the <a href="/wiki/False_Claims_Act" title="False Claims Act">False Claims Act</a>.<sup id="cite_ref-wapo_119-0" class="reference"><a href="#cite_note-wapo-119">[119]</a></sup> They alleged that Merck failed to pay proper rebates to <a href="/wiki/Medicaid" title="Medicaid">Medicaid</a> and other health care programs and paid illegal remuneration to health care providers.<sup id="cite_ref-120" class="reference"><a href="#cite_note-120">[120]</a></sup> On February 7, 2008 Merck agreed to pay more than $650 million to settle charges that it routinely overbilled Medicaid for its most popular medicines. The settlement was one of the <a href="/wiki/List_of_Largest_Pharmaceutical_Settlements" class="mw-redirect" title="List of Largest Pharmaceutical Settlements">largest pharmaceutical settlements</a> in history. The federal government received more than $360 million, plus 49 states and Washington, DC, received over $290 million. One whistleblower received a $68 million reward.<sup id="cite_ref-wapo_119-1" class="reference"><a href="#cite_note-wapo-119">[119]</a></sup><sup id="cite_ref-121" class="reference"><a href="#cite_note-121">[121]</a></sup> Merck made the settlement without an admission of liability or wrongdoing.<sup id="cite_ref-122" class="reference"><a href="#cite_note-122">[122]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Environmental_record">Environmental record</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=27" title="Edit section: Environmental record" data-section="27" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Merck &amp; Co. once used <a href="/wiki/Methylene_chloride" class="mw-redirect" title="Methylene chloride">methylene chloride</a>, an animal carcinogen on the <a href="/wiki/United_States_Environmental_Protection_Agency" title="United States Environmental Protection Agency">United States Environmental Protection Agency</a>'s list of pollutants, as a solvent in some of its manufacturing processes. Merck chemists and engineers subsequently replaced the compound with others having fewer negative environmental effects. Merck has also modified its equipment to protect the environment, installing a distributed control system that coordinates chemical reactions more efficiently and expedites manufacturing by 50 percent, eliminating the need for the disposal and storage of harmful waste. Biological oxygen demand has also been reduced.<sup id="cite_ref-123" class="reference"><a href="#cite_note-123">[123]</a></sup></p><p>In 1991, Merck's Kelco subsidiary was responsible for <a href="/wiki/Volatile_organic_compound" title="Volatile organic compound">volatile organic compound</a> (VOC) emission pollution in the San Diego area. In 1996 Merck paid $1.8 million for polluting the air. New machines were installed to reduce smog emissions by 680,000 lb (310,000 kg) a year.<sup id="cite_ref-124" class="reference"><a href="#cite_note-124">[124]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="MSD_for_Mothers">MSD for Mothers</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=28" title="Edit section: MSD for Mothers" data-section="28" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>MSD for Mothers is an associated not for profit organisation which supports projects to improve maternal health.<sup id="cite_ref-125" class="reference"><a href="#cite_note-125">[125]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(6)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=29" title="Edit section: See also" data-section="29" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-6 collapsible-block" id="mf-section-6">
<ul><li><a href="/wiki/Merck_family" title="Merck family">Merck family</a></li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(7)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Notes_and_references">Notes and references</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=30" title="Edit section: Notes and references" data-section="30" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-7 collapsible-block" id="mf-section-7">
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references"><li id="cite_note-10-K_2016-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-10-K_2016_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-10-K_2016_1-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/mrk1231201610k.htm">"US SEC: Form 10-K Merck &amp; Co., Inc"</a>. <a href="/wiki/United_States_Securities_and_Exchange_Commission" class="mw-redirect" title="United States Securities and Exchange Commission">United States Securities and Exchange Commission</a><span class="reference-accessdate">. Retrieved <span class="nowrap">January 12,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=US+SEC%3A+Form+10-K+Merck+%26+Co.%2C+Inc.&amp;rft.pub=United+States+Securities+and+Exchange+Commission&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F310158%2F000031015817000010%2Fmrk1231201610k.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><style data-mw-deduplicate="TemplateStyles:r935243608">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>
</li>
<li id="cite_note-Johnson2018-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Johnson2018_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Johnson2018_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Johnson, Linda (2 February 2018). <a rel="nofollow" class="external text" href="https://www.dddmag.com/news/2018/02/tax-overhaul-charge-hands-merck-4q-loss-despite-higher-sales">"Tax Overhaul Charge Hands Merck 4Q Loss Despite Higher Sales"</a>. <i>Drug Discovery &amp; Development Magazine</i>. Associated Press<span class="reference-accessdate">. Retrieved <span class="nowrap">2 February</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Discovery+%26+Development+Magazine&amp;rft.atitle=Tax+Overhaul+Charge+Hands+Merck+4Q+Loss+Despite+Higher+Sales&amp;rft.date=2018-02-02&amp;rft.aulast=Johnson&amp;rft.aufirst=Linda&amp;rft_id=https%3A%2F%2Fwww.dddmag.com%2Fnews%2F2018%2F02%2Ftax-overhaul-charge-hands-merck-4q-loss-despite-higher-sales&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-10-K_2017-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-10-K_2017_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-10-K_2017_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-10-K_2017_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-10-K_2017_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-10-K_2017_3-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-10-K_2017_3-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://s21.q4cdn.com/488056881/files/doc_financials/2018/Q4/2018-Form-10-K-(without-Exhibits)_FINAL_022719.pdf">"US SEC: Form 10-K Merck &amp; Co., Inc"</a> <span class="cs1-format">(PDF)</span>. <a href="/wiki/United_States_Securities_and_Exchange_Commission" class="mw-redirect" title="United States Securities and Exchange Commission">United States Securities and Exchange Commission</a><span class="reference-accessdate">. Retrieved <span class="nowrap">31 March</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=US+SEC%3A+Form+10-K+Merck+%26+Co.%2C+Inc.&amp;rft.pub=United+States+Securities+and+Exchange+Commission&amp;rft_id=https%3A%2F%2Fs21.q4cdn.com%2F488056881%2Ffiles%2Fdoc_financials%2F2018%2FQ4%2F2018-Form-10-K-%28without-Exhibits%29_FINAL_022719.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"> <cite id="CITEREF10-K2018" class="citation web"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/310158/31015819000014/0000310158-19-000014-index.htm">"10-K"</a>. <i>10-K</i><span class="reference-accessdate">. Retrieved <span class="nowrap">1 June</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=10-K&amp;rft.atitle=10-K&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F310158%2F31015819000014%2F0000310158-19-000014-index.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.merck.com/contact/home.html">"Contact Us"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">February 11,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Contact+Us&amp;rft_id=https%3A%2F%2Fwww.merck.com%2Fcontact%2Fhome.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://fortune.com/fortune500/list/">"Fortune 500 Companies 2018: Who Made the List"</a>. <i>Fortune</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2018-11-10</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Fortune&amp;rft.atitle=Fortune+500+Companies+2018%3A+Who+Made+the+List&amp;rft_id=https%3A%2F%2Ffortune.com%2Ffortune500%2Flist%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-:1-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-:1_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:1_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:1_7-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">The New York Times: <a rel="nofollow" class="external text" href="https://www.nytimes.com/2005/11/03/business/merck-bio.html">Key Facts About Merck</a>, November 3, 2005. Retrieved 2012-09-03.</span>
</li>
<li id="cite_note-:2-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-:2_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:2_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:2_8-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Voinea, Cosmina Lelia; Kranenburg, Hans Van (2017-07-14). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=OggqDwAAQBAJ&amp;lpg=PA134&amp;dq=Merck%20&amp;%20Co.%20operated%20from%201891%20to%201917%20as%20the%20US%20subsidiary%20of%20the%20Merck%20Group&amp;pg=PA134#v=snippet&amp;q=1891&amp;f=false"><i>Nonmarket Strategic Management</i></a>. Taylor &amp; Francis. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-1-317-42173-3" title="Special:BookSources/978-1-317-42173-3"><bdi>978-1-317-42173-3</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Nonmarket+Strategic+Management&amp;rft.pub=Taylor+%26+Francis&amp;rft.date=2017-07-14&amp;rft.isbn=978-1-317-42173-3&amp;rft.aulast=Voinea&amp;rft.aufirst=Cosmina+Lelia&amp;rft.au=Kranenburg%2C+Hans+Van&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DOggqDwAAQBAJ%26lpg%3DPA134%26dq%3DMerck%2520%26%2520Co.%2520operated%2520from%25201891%2520to%25201917%2520as%2520the%2520US%2520subsidiary%2520of%2520the%2520Merck%2520Group%26pg%3DPA134%23v%3Dsnippet%26q%3D1891%26f%3Dfalse&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><cite class="citation book">Rosen, William (2017). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=1FHSDgAAQBAJ&amp;lpg=PA159&amp;dq=US%20subsidiary%20Merck%20&amp;%20Co.%20was%20confiscated%20under%20the%20Trading%20with%20the%20Enemy%20Act%20of%201917&amp;pg=PA159#v=onepage&amp;q=US%20subsidiary%20merck%20confiscated%20&amp;f=false"><i>Miracle Cure: The Creation of Antibiotics and the Birth of Modern Medicine</i></a>. Penguin. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-525-42810-7" title="Special:BookSources/978-0-525-42810-7"><bdi>978-0-525-42810-7</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Miracle+Cure%3A+The+Creation+of+Antibiotics+and+the+Birth+of+Modern+Medicine&amp;rft.pub=Penguin&amp;rft.date=2017&amp;rft.isbn=978-0-525-42810-7&amp;rft.aulast=Rosen&amp;rft.aufirst=William&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D1FHSDgAAQBAJ%26lpg%3DPA159%26dq%3DUS%2520subsidiary%2520Merck%2520%26%2520Co.%2520was%2520confiscated%2520under%2520the%2520Trading%2520with%2520the%2520Enemy%2520Act%2520of%25201917%26pg%3DPA159%23v%3Donepage%26q%3DUS%2520subsidiary%2520merck%2520confiscated%2520%26f%3Dfalse&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-apc1919-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-apc1919_10-0">^</a></b></span> <span class="reference-text"><cite class="citation journal"><a href="/wiki/A._Mitchell_Palmer" title="A. Mitchell Palmer">Palmer, A. Mitchell</a> (April 1919). "Report of the alien property custodian on the chemical industry". <i><a href="/wiki/Ind._Eng._Chem." class="mw-redirect" title="Ind. Eng. Chem.">Ind. Eng. Chem.</a></i> <b>11</b> (4): 364. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1021%2Fie50112a030">10.1021/ie50112a030</a>. <q>I am of the opinion, however, that indirect ownership of this kind cannot be recognized under the Trading-with-the-Enemy Act, and I have, therefore, determined that the whole of this stock is enemy owned and it has accordingly been taken over.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ind.+Eng.+Chem.&amp;rft.atitle=Report+of+the+alien+property+custodian+on+the+chemical+industry&amp;rft.volume=11&amp;rft.issue=4&amp;rft.pages=364&amp;rft.date=1919-04&amp;rft_id=info%3Adoi%2F10.1021%2Fie50112a030&amp;rft.aulast=Palmer&amp;rft.aufirst=A.+Mitchell&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><span style="position:relative; top: -2px;"><a href="/wiki/Open_access" title="open access publication – free to read"><noscript><img alt="open access" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/9px-Open_Access_logo_PLoS_transparent.svg.png" decoding="async" width="9" height="14" data-file-width="640" data-file-height="1000"></noscript><span class="lazy-image-placeholder" style="width: 9px;height: 14px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/9px-Open_Access_logo_PLoS_transparent.svg.png" data-alt="open access" data-width="9" data-height="14" data-srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/14px-Open_Access_logo_PLoS_transparent.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/18px-Open_Access_logo_PLoS_transparent.svg.png 2x"> </span></a></span></span>
</li>
<li id="cite_note-genengnews.com-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-genengnews.com_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-genengnews.com_11-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.genengnews.com/gen-news-highlights/legal-wrangle-pits-merck-vs-merck/81252246/">"Legal Wrangle Pits Merck vs. Merck"</a>. <i>Genetic Engineering &amp; Biotechnology News</i>. January 15, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=Legal+Wrangle+Pits+Merck+vs.+Merck&amp;rft.date=2016-01-15&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Flegal-wrangle-pits-merck-vs-merck%2F81252246%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><cite class="citation book">Galambos, Louis; Sewell, Jane Eliot (1997-08-13). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=b8WaKnyfRFIC&amp;lpg=PA28&amp;dq=merck%20and%20co%201929%20vaccine&amp;pg=PA28#v=onepage&amp;q=merck%20and%20co%201929%20vaccine&amp;f=false"><i>Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995</i></a>. Cambridge University Press. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-521-62620-0" title="Special:BookSources/978-0-521-62620-0"><bdi>978-0-521-62620-0</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Networks+of+Innovation%3A+Vaccine+Development+at+Merck%2C+Sharp+and+Dohme%2C+and+Mulford%2C+1895-1995&amp;rft.pub=Cambridge+University+Press&amp;rft.date=1997-08-13&amp;rft.isbn=978-0-521-62620-0&amp;rft.aulast=Galambos&amp;rft.aufirst=Louis&amp;rft.au=Sewell%2C+Jane+Eliot&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Db8WaKnyfRFIC%26lpg%3DPA28%26dq%3Dmerck%2520and%2520co%25201929%2520vaccine%26pg%3DPA28%23v%3Donepage%26q%3Dmerck%2520and%2520co%25201929%2520vaccine%26f%3Dfalse&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text">Time Magazine: <a rel="nofollow" class="external text" href="https://www.time.com/time/magazine/article/0,9171,935871,00.html">Merck's Merger</a>, March 16, 1953. Retrieved 2012-09-03.</span>
</li>
<li id="cite_note-:3-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-:3_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:3_14-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-merckkgaa-name-idUSKCN0UT239/">"Fight over Merck name sees German firm win in British court"</a>. <i>Reuters</i>. January 15, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Fight+over+Merck+name+sees+German+firm+win+in+British+court&amp;rft.date=2016-01-15&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-merckkgaa-name-idUSKCN0UT239%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.thestar.com/business/article/833712--montreal-plant-among-17-closed-by-drugmaker-merck">"Montreal plant among 17 closed by drugmaker Merck"</a>. <i>The Star</i>. Toronto. July 8, 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Star&amp;rft.atitle=Montreal+plant+among+17+closed+by+drugmaker+Merck&amp;rft.date=2010-07-08&amp;rft_id=https%3A%2F%2Fwww.thestar.com%2Fbusiness%2Farticle%2F833712--montreal-plant-among-17-closed-by-drugmaker-merck&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-2013-10K-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-2013-10K_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-2013-10K_16-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation report">Merck &amp; Co., Inc. (27 Feb 2014). Merck &amp; CO, Inc 2013 FORM 10-K (Report).</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=report&amp;rft.btitle=Merck+%26+CO%2C+Inc+2013+FORM+10-K&amp;rft.date=2014-02-27&amp;rft.au=Merck+%26+Co.%2C+Inc.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.baltimoresun.com/news/bs-xpm-1993-11-19-1993323090-story.html">"Merck &amp; Co. completes Medco purchase"</a>. <i>Baltimore Sun</i>. New York Times News Service. November 19, 1993<span class="reference-accessdate">. Retrieved <span class="nowrap">May 29,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Baltimore+Sun&amp;rft.atitle=Merck+%26+Co.+completes+Medco+purchase&amp;rft.date=1993-11-19&amp;rft_id=https%3A%2F%2Fwww.baltimoresun.com%2Fnews%2Fbs-xpm-1993-11-19-1993323090-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://usatoday30.usatoday.com/money/industries/health/drugs/2003-08-20-merck-medco_x.htm">"Merck finally spins off Medco Health to shareholders"</a>. <i>USA Today</i>. Associated Press. August 20, 2003.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=USA+Today&amp;rft.atitle=Merck+finally+spins+off+Medco+Health+to+shareholders&amp;rft.date=2003-08-20&amp;rft_id=https%3A%2F%2Fusatoday30.usatoday.com%2Fmoney%2Findustries%2Fhealth%2Fdrugs%2F2003-08-20-merck-medco_x.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><cite class="citation news">Singer, Natasha (March 10, 2009). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2009/03/10/business/10drug.html">"Merck to Buy Schering-Plough for $41.1 Billion"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2009-11-14</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Merck+to+Buy+Schering-Plough+for+%2441.1+Billion&amp;rft.date=2009-03-10&amp;rft.aulast=Singer&amp;rft.aufirst=Natasha&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F03%2F10%2Fbusiness%2F10drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160201164618/http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MjA0NDh8Q2hpbGRJRD0tMXxUeXBlPTM=&amp;t=1">"Notice of Reorganization Event"</a>. November 12, 2009. Archived from <a rel="nofollow" class="external text" href="http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MjA0NDh8Q2hpbGRJRD0tMXxUeXBlPTM=&amp;t=1">the original</a> on February 1, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-11-13</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Notice+of+Reorganization+Event&amp;rft.date=2009-11-12&amp;rft_id=http%3A%2F%2Fphx.corporate-ir.net%2FExternal.File%3Fitem%3DUGFyZW50SUQ9MjA0NDh8Q2hpbGRJRD0tMXxUeXBlPTM%3D%26t%3D1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><cite class="citation news">Edwards, Jim (November 10, 2009). <a rel="nofollow" class="external text" href="https://www.cbsnews.com/8301-505123_162-42843442/merck-legally-changed-its-name-3-times-to-achieve-reverse-merger-with-schering/">"Merck Legally Changed Its Name 3 Times to Achieve Reverse Merger With Schering"</a>. <i>CBS News</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2012-09-02</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=Merck+Legally+Changed+Its+Name+3+Times+to+Achieve+Reverse+Merger+With+Schering&amp;rft.date=2009-11-10&amp;rft.aulast=Edwards&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2F8301-505123_162-42843442%2Fmerck-legally-changed-its-name-3-times-to-achieve-reverse-merger-with-schering%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120708195540/http://www.merck.com/newsroom/news-release-archive/corporate/2011_0415.html">"Merck and Johnson &amp; Johnson Reach Agreement on Distribution Rights for Remicade and Simponi"</a> (Press release). Merck &amp; Co. Business Wire. April 15, 2011. Archived from <a rel="nofollow" class="external text" href="https://www.mrknewsroom.com/press-release/corporate-news/merck-and-johnson-johnson-reach-agreement-distribution-rights-remicade-">the original</a> on 2012-07-08<span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Merck+and+Johnson+%26+Johnson+Reach+Agreement+on+Distribution+Rights+for+Remicade+and+Simponi&amp;rft.pub=Merck+%26+Co.&amp;rft.date=2011-04-15&amp;rft_id=https%3A%2F%2Fwww.mrknewsroom.com%2Fpress-release%2Fcorporate-news%2Fmerck-and-johnson-johnson-reach-agreement-distribution-rights-remicade-&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-merck-scheringplough-idUSTRE5A23YZ20091103">"Merck, Schering-Plough set to complete merger"</a>. <i>Reuters</i>. 2009-11-03<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-04-01</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Merck%2C+Schering-Plough+set+to+complete+merger&amp;rft.date=2009-11-03&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-merck-scheringplough-idUSTRE5A23YZ20091103&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-:0-24"><span class="mw-cite-backlink">^ <a href="#cite_ref-:0_24-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:0_24-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:0_24-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Jeffrey, Jeff (25 August 2015). <a rel="nofollow" class="external text" href="http://www.bizjournals.com/triangle/news/2015/08/25/merck-sues-taiwan-company-over-generic-antibiotic.html">"Merck sues Taiwan company over generic antibiotic product"</a>. <i><a href="/wiki/Triangle_Bus._J." class="mw-redirect" title="Triangle Bus. J.">Triangle Business Journal</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">2015-08-26</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Triangle+Business+Journal&amp;rft.atitle=Merck+sues+Taiwan+company+over+generic+antibiotic+product&amp;rft.date=2015-08-25&amp;rft.aulast=Jeffrey&amp;rft.aufirst=Jeff&amp;rft_id=http%3A%2F%2Fwww.bizjournals.com%2Ftriangle%2Fnews%2F2015%2F08%2F25%2Fmerck-sues-taiwan-company-over-generic-antibiotic.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.merckresponsibility.com/giving-at-merck/foundation/">"Foundation » Merck Responsibility"</a>. <i>Merck Responsibility</i><span class="reference-accessdate">. Retrieved <span class="nowrap">3 July</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Merck+Responsibility&amp;rft.atitle=Foundation+%C2%BB+Merck+Responsibility&amp;rft_id=https%3A%2F%2Fwww.merckresponsibility.com%2Fgiving-at-merck%2Ffoundation%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.merck.com/cr/docs/Merck_Global_Health_Scholars_Press_Release_5_22_07.pdf">"Princeton University and The Merck Company Foundation Announce Creation Of New Global Health Scholars Program and Lecture Series"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">2012-06-05</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Princeton+University+and+The+Merck+Company+Foundation+Announce+Creation+Of+New+Global+Health+Scholars+Program+and+Lecture+Series&amp;rft_id=https%3A%2F%2Fwww.merck.com%2Fcr%2Fdocs%2FMerck_Global_Health_Scholars_Press_Release_5_22_07.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text">Scouts for Equality: <a rel="nofollow" class="external text" href="http://www.scoutsforequality.com/campaign-news/merck-pauses-boy-scout-funding/">Merck pauses Boy Scout Funding</a>, accessed December 10, 2012</span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.bbc.co.uk/news/business-24356801">"Merck cuts another 8,500 jobs"</a>. <i>BBC News</i>. October 1, 2013.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Merck+cuts+another+8%2C500+jobs&amp;rft.date=2013-10-01&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-24356801&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.genengnews.com/gen-news-highlights/merck-co-acquires-idenix-for-3-85b-adding-to-hcv-portfolio/81249955/">"Merck acquires Idenix"</a>. <i>Genetic engineering &amp; biotechnology news</i>. June 9, 2014.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genetic+engineering+%26+biotechnology+news&amp;rft.atitle=Merck+acquires+Idenix&amp;rft.date=2014-06-09&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fmerck-co-acquires-idenix-for-3-85b-adding-to-hcv-portfolio%2F81249955%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><cite class="citation web">Rothwell, Steve. <a rel="nofollow" class="external text" href="https://abcnews.go.com/Business/wireStory/merger-momentum-continue-2015-ey-27453774">"Merger Momentum to Continue in 2015, EY Says"</a>. abc news<span class="reference-accessdate">. Retrieved <span class="nowrap">9 December</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Merger+Momentum+to+Continue+in+2015%2C+EY+Says&amp;rft.pub=abc+news&amp;rft.aulast=Rothwell&amp;rft.aufirst=Steve&amp;rft_id=https%3A%2F%2Fabcnews.go.com%2FBusiness%2FwireStory%2Fmerger-momentum-continue-2015-ey-27453774&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.genengnews.com/gen-news-highlights/merck-buys-oncoethix-for-up-to-375m/81250717/">"Merck Buys OncoEthix for up to $375M"</a>. <i>Genetic Engineering &amp; Biotechnology News</i>. December 18, 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">May 29,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=Merck+Buys+OncoEthix+for+up+to+%24375M&amp;rft.date=2014-12-18&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fmerck-buys-oncoethix-for-up-to-375m%2F81250717%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.genengnews.com/gen-news-highlights/ablynx-merck-co-ink-4b-expansion-of-immuno-oncology-collaboration/81251532/">"Ablynx, Merck &amp; Co. Ink $4B+ Expansion of Immuno-Oncology Collaboration"</a>. <i>Genetic Engineering &amp; Biotechnology News</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=Ablynx%2C+Merck+%26+Co.+Ink+%244B%2B+Expansion+of+Immuno-Oncology+Collaboration&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fablynx-merck-co-ink-4b-expansion-of-immuno-oncology-collaboration%2F81251532%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.fiercebiotech.com/story/merck-signs-605m-deal-bulk-cancer-immunotherapy/2015-07-28">"Merck signs a $605M deal to bulk up in cancer immunotherapy"</a>. <i>FierceBiotech</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FierceBiotech&amp;rft.atitle=Merck+signs+a+%24605M+deal+to+bulk+up+in+cancer+immunotherapy&amp;rft_id=https%3A%2F%2Fwww.fiercebiotech.com%2Fstory%2Fmerck-signs-605m-deal-bulk-cancer-immunotherapy%2F2015-07-28&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.genengnews.com/gen-news-highlights/quartet-merck-partner-on-pain-treatments-in-up-to-595m-alliance/81252184/">"Quartet, Merck Partner on Pain Treatments in Up-to-$595M Alliance"</a>. <i>Genetic Engineering &amp; Biotechnology News</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=Quartet%2C+Merck+Partner+on+Pain+Treatments+in+Up-to-%24595M+Alliance&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fquartet-merck-partner-on-pain-treatments-in-up-to-595m-alliance%2F81252184%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.genengnews.com/gen-news-highlights/merck-co-launches-up-to-280m-cancer-collaboration-with-complix/81252183/">"Merck &amp; Co. Launches Up-to-$280M Cancer Collaboration with Complix"</a>. <i>Genetic Engineering &amp; Biotechnology News</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=Merck+%26+Co.+Launches+Up-to-%24280M+Cancer+Collaboration+with+Complix&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fmerck-co-launches-up-to-280m-cancer-collaboration-with-complix%2F81252183%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.genengnews.com/gen-news-highlights/merck-co-acquires-cancer-immunotherapy-developer-iomet/81252220/">"Merck &amp; Co. Acquires Cancer Immunotherapy Developer IOmet"</a>. <i>Genetic Engineering &amp; Biotechnology News</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=Merck+%26+Co.+Acquires+Cancer+Immunotherapy+Developer+IOmet&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fmerck-co-acquires-cancer-immunotherapy-developer-iomet%2F81252220%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.genengnews.com/news/merck-co-to-acquire-afferent-pharmaceuticals-for-up-to-1-25b/81252815/">"Merck &amp; Co. to Acquire Afferent Pharmaceuticals for Up to $1.25B"</a>. <i>Genetic Engineering &amp; Biotechnology News</i>. June 10, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=Merck+%26+Co.+to+Acquire+Afferent+Pharmaceuticals+for+Up+to+%241.25B&amp;rft.date=2016-06-10&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fmerck-co-to-acquire-afferent-pharmaceuticals-for-up-to-1-25b%2F81252815%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://www.mrknewsroom.com/news-release/corporate-news/merck-animal-health-completes-acquisition-vallee-sa">"Merck Animal Health Completes Acquisition of Vallée S.A."</a> (Press release). Merck &amp; Co. Business Wire. March 22, 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Merck+Animal+Health+Completes+Acquisition+of+Vall%C3%A9e+S.A.&amp;rft.pub=Merck+%26+Co.&amp;rft.date=2017-03-22&amp;rft_id=https%3A%2F%2Fwww.mrknewsroom.com%2Fnews-release%2Fcorporate-news%2Fmerck-animal-health-completes-acquisition-vallee-sa&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.genengnews.com/topics/drug-discovery/merck-to-acquire-rigontec-expanding-cancer-immunotherapy-franchise/">"Merck to Acquire Rigontec, Expanding Cancer Immunotherapy Franchise"</a>. <i>Genetic Engineering &amp; Biotechnology News</i>. September 6, 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=Merck+to+Acquire+Rigontec%2C+Expanding+Cancer+Immunotherapy+Franchise&amp;rft.date=2017-09-06&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fmerck-to-acquire-rigontec-expanding-cancer-immunotherapy-franchise%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><cite class="citation news">Hirschler, Ben (February 21, 2018). <a rel="nofollow" class="external text" href="https://uk.reuters.com/article/us-viralytics-m-a-merck-co/merck-to-buy-virus-based-cancer-drug-firm-viralytics-for-394-million-idUKKCN1G50ZN/">"Merck to buy virus-based cancer drug firm Viralytics for $394 million"</a>. <i>Reuters</i><span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Merck+to+buy+virus-based+cancer+drug+firm+Viralytics+for+%24394+million&amp;rft.date=2018-02-21&amp;rft.aulast=Hirschler&amp;rft.aufirst=Ben&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-viralytics-m-a-merck-co%2Fmerck-to-buy-virus-based-cancer-drug-firm-viralytics-for-394-million-idUKKCN1G50ZN%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><cite class="citation news">Mathias, Tamara (December 14, 2018). <a rel="nofollow" class="external text" href="https://uk.reuters.com/article/uk-antelliq-m-a-merck-co/merck-bolsters-animal-health-unit-with-2-4-billion-antelliq-purchase-idUKKBN1OD1N4">"Merck bolsters animal health unit with $2.4 billion Antelliq purchase"</a>. <i>Reuters</i><span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Merck+bolsters+animal+health+unit+with+%242.4+billion+Antelliq+purchase&amp;rft.date=2018-12-14&amp;rft.aulast=Mathias&amp;rft.aufirst=Tamara&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fuk-antelliq-m-a-merck-co%2Fmerck-bolsters-animal-health-unit-with-2-4-billion-antelliq-purchase-idUKKBN1OD1N4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://uk.reuters.com/article/us-immune-design-merck-co-m-a/merck-to-buy-immunotherapy-developer-immune-design-for-300-million-idUKKCN1QA1HP/">"Merck to buy immunotherapy developer Immune Design for $300 million"</a>. <i>Reuters</i>. February 21, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Merck+to+buy+immunotherapy+developer+Immune+Design+for+%24300+million&amp;rft.date=2019-02-21&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-immune-design-merck-co-m-a%2Fmerck-to-buy-immunotherapy-developer-immune-design-for-300-million-idUKKCN1QA1HP%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><cite class="citation news">Keown, Alex (February 21, 2019). <a rel="nofollow" class="external text" href="https://www.biospace.com/article/merck-acquires-immune-design-for-300-million-in-cash/">"Merck Acquires Immune Design for $300 Million in Cash"</a>. <i>BioSpace</i><span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BioSpace&amp;rft.atitle=Merck+Acquires+Immune+Design+for+%24300+Million+in+Cash&amp;rft.date=2019-02-21&amp;rft.aulast=Keown&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fmerck-acquires-immune-design-for-300-million-in-cash%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><cite class="citation news">Terry, Mark (May 21, 2019). <a rel="nofollow" class="external text" href="https://www.biospace.com/article/merck-buys-peloton-therapeutics-in-2-2-billion-deal/">"Merck Buys Peloton Therapeutics in $2.2 Billion Deal"</a>. <i>BioSpace</i><span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BioSpace&amp;rft.atitle=Merck+Buys+Peloton+Therapeutics+in+%242.2+Billion+Deal&amp;rft.date=2019-05-21&amp;rft.aulast=Terry&amp;rft.aufirst=Mark&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fmerck-buys-peloton-therapeutics-in-2-2-billion-deal%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://uk.reuters.com/article/us-tilos-therapeutics-m-a-merck-idUKKCN1TB19J">"Merck to buy Tilos Therapeutics for up to $773 million"</a>. <i>Reuters</i>. 2019-06-10<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-03-10</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Merck+to+buy+Tilos+Therapeutics+for+up+to+%24773+million&amp;rft.date=2019-06-10&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-tilos-therapeutics-m-a-merck-idUKKCN1TB19J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/merck-snaps-up-calporta-in-576-million-deal-for-preclinical-neurodegenerative-asset/">"Merck Snaps Up Preclinical Neurodegenerative Asset in $576 Million Buy"</a>. <i>BioSpace</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-03-10</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Merck+Snaps+Up+Preclinical+Neurodegenerative+Asset+in+%24576+Million+Buy&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fmerck-snaps-up-calporta-in-576-million-deal-for-preclinical-neurodegenerative-asset%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/merck-to-acquire-arqule-advancing-leadership-in-oncology/">"Merck to Acquire ArQule, Advancing Leadership in Oncology"</a>. <i>BioSpace</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-03-10</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Merck+to+Acquire+ArQule%2C+Advancing+Leadership+in+Oncology&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fmerck-to-acquire-arqule-advancing-leadership-in-oncology%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/merck-snaps-up-arqule-and-its-btk-cancer-drug-in-2-7-billion-deal/">"Merck Snaps Up ArQule and Its BTK Cancer Drug in $2.7 Billion Deal"</a>. <i>BioSpace</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-03-10</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Merck+Snaps+Up+ArQule+and+Its+BTK+Cancer+Drug+in+%242.7+Billion+Deal&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fmerck-snaps-up-arqule-and-its-btk-cancer-drug-in-2-7-billion-deal%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/merck-animal-health-completes-acquisition-of-vaki-to-further-broaden-its-leadership-position-in-aquaculture-to-advance-fish-health-and-welfare/">"Merck Animal Health Completes Acquisition of Vaki to Further Broaden Its Leadership Position in Aquaculture to Advance Fish Health and Welfare"</a>. <i>BioSpace</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-03-10</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Merck+Animal+Health+Completes+Acquisition+of+Vaki+to+Further+Broaden+Its+Leadership+Position+in+Aquaculture+to+Advance+Fish+Health+and+Welfare&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fmerck-animal-health-completes-acquisition-of-vaki-to-further-broaden-its-leadership-position-in-aquaculture-to-advance-fish-health-and-welfare%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.mrknewsroom.com/news-release/corporate-news/merck-focus-key-growth-pillars-through-spinoff-womens-health-trusted-leg">"Merck to Focus on Key Growth Pillars Through Spinoff of Women's Health, Trusted Legacy Brands and Biosimilars Products into New Company ("NewCo") | Merck Newsroom Home"</a>. <i>mrknewsroom.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-02-05</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=mrknewsroom.com&amp;rft.atitle=Merck+to+Focus+on+Key+Growth+Pillars+Through+Spinoff+of+Women%27s+Health%2C+Trusted+Legacy+Brands+and+Biosimilars+Products+into+New+Company+%28%22NewCo%22%29+%7C+Merck+Newsroom+Home&amp;rft_id=https%3A%2F%2Fwww.mrknewsroom.com%2Fnews-release%2Fcorporate-news%2Fmerck-focus-key-growth-pillars-through-spinoff-womens-health-trusted-leg&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://njbmagazine.com/monthly-articles/inaugural-manufacturing-awards/">"You are being redirected..."</a> <i>njbmagazine.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-03-12</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=njbmagazine.com&amp;rft.atitle=You+are+being+redirected...&amp;rft_id=https%3A%2F%2Fnjbmagazine.com%2Fmonthly-articles%2Finaugural-manufacturing-awards%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Bloomberg14-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-Bloomberg14_52-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Connolly, Allison; Kitamura, Makiko (February 10, 2014). <span class="cs1-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/articles/2014-02-10/a-tale-of-two-mercks-as-protesters-take-on-wrong-company">"A Tale of Two Mercks as Protesters Take On Wrong Company"</a></span>. <i>Bloomberg</i><span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg&amp;rft.atitle=A+Tale+of+Two+Mercks+as+Protesters+Take+On+Wrong+Company&amp;rft.date=2014-02-10&amp;rft.aulast=Connolly&amp;rft.aufirst=Allison&amp;rft.au=Kitamura%2C+Makiko&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2014-02-10%2Fa-tale-of-two-mercks-as-protesters-take-on-wrong-company&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.nasdaq.com/article/merck-kgaa-announces-favorable-english-court-ruling-on-name-use-20160115-00359#ixzz41CPkGqNI">"Today's Stock Market News and Analysis from Nasdaq.com"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Today%27s+Stock+Market+News+and+Analysis+from+Nasdaq.com&amp;rft_id=http%3A%2F%2Fwww.nasdaq.com%2Farticle%2Fmerck-kgaa-announces-favorable-english-court-ruling-on-name-use-20160115-00359%23ixzz41CPkGqNI&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://d1lge852tjjqow.cloudfront.net/CIK-0000310158/8f20baa9-c05b-416f-b083-927819a975f0.pdf">http://d1lge852tjjqow.cloudfront.net/CIK-0000310158/8f20baa9-c05b-416f-b083-927819a975f0.pdf</a></span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://investors.merck.com/financials/sec-filings/sec-filings-details/default.aspx?FilingId=10420422">https://investors.merck.com/financials/sec-filings/sec-filings-details/default.aspx?FilingId=10420422</a></span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://d18rn0p25nwr6d.cloudfront.net/CIK-0000064978/eda8fca7-7bcd-43dc-8ab5-2705488c9ba4.pdf">http://d18rn0p25nwr6d.cloudfront.net/CIK-0000064978/eda8fca7-7bcd-43dc-8ab5-2705488c9ba4.pdf</a></span>
</li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><cite class="citation news">Rubin, Ben Fox (2011-10-06). <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/SB10001424052970203476804576614994135927176">"Merck Chairman Clark To Retire; CEO Frazier to Take Over"</a>. <i>Wall Street Journal</i><span class="reference-accessdate">. Retrieved <span class="nowrap">24 November</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Wall+Street+Journal&amp;rft.atitle=Merck+Chairman+Clark+To+Retire%3B+CEO+Frazier+to+Take+Over&amp;rft.date=2011-10-06&amp;rft.aulast=Rubin&amp;rft.aufirst=Ben+Fox&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB10001424052970203476804576614994135927176&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-apmerckcfo2014-58"><span class="mw-cite-backlink">^ <a href="#cite_ref-apmerckcfo2014_58-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-apmerckcfo2014_58-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://www.dddmag.com/news/2014/03/merck-replacing-cfo-baxter-exec">"Merck Replacing CFO with Baxter Exec"</a>. <i>Drug Discovery &amp; Development</i>. United States of America: Advantage Business Media. Associated Press. March 27, 2014. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140329001923/http://www.dddmag.com/news/2014/03/merck-replacing-cfo-baxter-exec">Archived</a> from the original on March 29, 2014.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Discovery+%26+Development&amp;rft.atitle=Merck+Replacing+CFO+with+Baxter+Exec&amp;rft.date=2014-03-27&amp;rft_id=http%3A%2F%2Fwww.dddmag.com%2Fnews%2F2014%2F03%2Fmerck-replacing-cfo-baxter-exec&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><cite class="citation journal">Kinch MS, Haynesworth A, Kinch SL, Hoyer D (August 2014). "An overview of FDA-approved new molecular entities: 1827-2013". <i>Drug Discov. Today</i>. <b>19</b> (8): 1033–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.drudis.2014.03.018">10.1016/j.drudis.2014.03.018</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24680947">24680947</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Discov.+Today&amp;rft.atitle=An+overview+of+FDA-approved+new+molecular+entities%3A+1827-2013&amp;rft.volume=19&amp;rft.issue=8&amp;rft.pages=1033-9&amp;rft.date=2014-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.drudis.2014.03.018&amp;rft_id=info%3Apmid%2F24680947&amp;rft.aulast=Kinch&amp;rft.aufirst=MS&amp;rft.au=Haynesworth%2C+A&amp;rft.au=Kinch%2C+SL&amp;rft.au=Hoyer%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/mrk1231201310k.htm">"sec.gov"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=sec.gov&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F310158%2F000031015814000009%2Fmrk1231201310k.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><cite class="citation web">Palmer, Eric (June 17, 2014). <a rel="nofollow" class="external text" href="https://www.fiercepharma.com/pharma/top-10-best-selling-diabetes-drugs-of-2013">"The top 10 best-selling diabetes drugs of 2013"</a>. <i>FiercePharma</i><span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FiercePharma&amp;rft.atitle=The+top+10+best-selling+diabetes+drugs+of+2013&amp;rft.date=2014-06-17&amp;rft.aulast=Palmer&amp;rft.aufirst=Eric&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Ftop-10-best-selling-diabetes-drugs-of-2013&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><cite class="citation journal">Zhan M, Xu T, Wu F, Tang Y (August 2012). "Sitagliptin in the treatment of type 2 diabetes: a meta-analysis". <i>J Evid Based Med</i>. <b>5</b> (3): 154–65. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1756-5391.2012.01189.x">10.1111/j.1756-5391.2012.01189.x</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23672222">23672222</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Evid+Based+Med&amp;rft.atitle=Sitagliptin+in+the+treatment+of+type+2+diabetes%3A+a+meta-analysis&amp;rft.volume=5&amp;rft.issue=3&amp;rft.pages=154-65&amp;rft.date=2012-08&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1756-5391.2012.01189.x&amp;rft_id=info%3Apmid%2F23672222&amp;rft.aulast=Zhan&amp;rft.aufirst=M&amp;rft.au=Xu%2C+T&amp;rft.au=Wu%2C+F&amp;rft.au=Tang%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><cite class="citation journal">Deacon CF, Mannucci E, Ahrén B (August 2012). "Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis". <i>Diabetes Obes Metab</i>. <b>14</b> (8): 762–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1463-1326.2012.01603.x">10.1111/j.1463-1326.2012.01603.x</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22471248">22471248</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Diabetes+Obes+Metab&amp;rft.atitle=Glycaemic+efficacy+of+glucagon-like+peptide-1+receptor+agonists+and+dipeptidyl+peptidase-4+inhibitors+as+add-on+therapy+to+metformin+in+subjects+with+type+2+diabetes-a+review+and+meta+analysis&amp;rft.volume=14&amp;rft.issue=8&amp;rft.pages=762-7&amp;rft.date=2012-08&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1463-1326.2012.01603.x&amp;rft_id=info%3Apmid%2F22471248&amp;rft.aulast=Deacon&amp;rft.aufirst=CF&amp;rft.au=Mannucci%2C+E&amp;rft.au=Ahr%C3%A9n%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><cite class="citation journal">Li L, Shen J, Bala MM,  et al. (2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3987051">"Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies"</a>. <i>BMJ</i>. <b>348</b>: g2366. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.g2366">10.1136/bmj.g2366</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3987051">3987051</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24736555">24736555</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Incretin+treatment+and+risk+of+pancreatitis+in+patients+with+type+2+diabetes+mellitus%3A+systematic+review+and+meta-analysis+of+randomised+and+non-randomised+studies&amp;rft.volume=348&amp;rft.pages=g2366&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3987051&amp;rft_id=info%3Apmid%2F24736555&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.g2366&amp;rft.aulast=Li&amp;rft.aufirst=L&amp;rft.au=Shen%2C+J&amp;rft.au=Bala%2C+MM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3987051&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://www.medpagetoday.com/MeetingCoverage/AHA/48637">"AHA: IMPROVE-IT Proves Ezetimibe Benefit"</a>. <i>MedpageToday</i>. November 17, 2014.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MedpageToday&amp;rft.atitle=AHA%3A+IMPROVE-IT+Proves+Ezetimibe+Benefit&amp;rft.date=2014-11-17&amp;rft_id=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAHA%2F48637&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><cite class="citation journal">Aaltonen KJ, Virkki LM, Malmivaara A, Konttinen YT, Nordström DC, Blom M (2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3260264">"Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis"</a>. <i>PLOS ONE</i>. <b>7</b> (1): e30275. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2012PLoSO...730275A">2012PLoSO...730275A</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0030275">10.1371/journal.pone.0030275</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3260264">3260264</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22272322">22272322</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=Systematic+review+and+meta-analysis+of+the+efficacy+and+safety+of+existing+TNF+blocking+agents+in+treatment+of+rheumatoid+arthritis&amp;rft.volume=7&amp;rft.issue=1&amp;rft.pages=e30275&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3260264&amp;rft_id=info%3Apmid%2F22272322&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0030275&amp;rft_id=info%3Abibcode%2F2012PLoSO...730275A&amp;rft.aulast=Aaltonen&amp;rft.aufirst=KJ&amp;rft.au=Virkki%2C+LM&amp;rft.au=Malmivaara%2C+A&amp;rft.au=Konttinen%2C+YT&amp;rft.au=Nordstr%C3%B6m%2C+DC&amp;rft.au=Blom%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3260264&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.mrknewsroom.com/press-release/corporate-news/merck-and-johnson-johnson-reach-agreement-distribution-rights-remicade-">"Merck and Johnson &amp; Johnson Reach Agreement on Distribution Rights for REMICADE® and SIMPONI® | Merck Newsroom Home"</a>. <i>mrknewsroom.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-05-08</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=mrknewsroom.com&amp;rft.atitle=Merck+and+Johnson+%26+Johnson+Reach+Agreement+on+Distribution+Rights+for+REMICADE%C2%AE+and+SIMPONI%C2%AE+%7C+Merck+Newsroom+Home&amp;rft_id=https%3A%2F%2Fwww.mrknewsroom.com%2Fpress-release%2Fcorporate-news%2Fmerck-and-johnson-johnson-reach-agreement-distribution-rights-remicade-&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.genengnews.com/topics/drug-discovery/merck-samsung-bioepis-launch-remicade-biosimilar-in-u-s/">"Merck, Samsung Bioepis Launch Remicade Biosimilar in U.S."</a> <i>Genetic Engineering &amp; Biotechnology News</i>. 2017-07-24<span class="reference-accessdate">. Retrieved <span class="nowrap">2019-05-08</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=Merck%2C+Samsung+Bioepis+Launch+Remicade+Biosimilar+in+U.S.&amp;rft.date=2017-07-24&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fmerck-samsung-bioepis-launch-remicade-biosimilar-in-u-s%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><cite class="citation web"> <span class="cs1-format">(PDF)</span> <a rel="nofollow" class="external text" href="https://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf">https://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fwww.merck.com%2Fproduct%2Fusa%2Fpi_circulars%2Fg%2Fgardasil%2Fgardasil_pi.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span> <span class="cs1-visible-error error citation-comment">Missing or empty <code class="cs1-code">|title=</code> (<a href="/wiki/Help:CS1_errors#citation_missing_title" title="Help:CS1 errors">help</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><cite class="citation web"> <span class="cs1-format">(PDF)</span> <a rel="nofollow" class="external text" href="https://www.merck.com/product/usa/pi_circulars/i/isentress/isentress_pi.pdf">https://www.merck.com/product/usa/pi_circulars/i/isentress/isentress_pi.pdf</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fwww.merck.com%2Fproduct%2Fusa%2Fpi_circulars%2Fi%2Fisentress%2Fisentress_pi.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span> <span class="cs1-visible-error error citation-comment">Missing or empty <code class="cs1-code">|title=</code> (<a href="/wiki/Help:CS1_errors#citation_missing_title" title="Help:CS1 errors">help</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf">"aidsinfo.nih.gov"</a> <span class="cs1-format">(PDF)</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=aidsinfo.nih.gov&amp;rft_id=http%3A%2F%2Faidsinfo.nih.gov%2Fcontentfiles%2Flvguidelines%2Fadultandadolescentgl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.genengnews.com/gen-news-highlights/merck-melanoma-drug-is-first-pd-1-inhibitor-ok-d-by-fda/81250309/">"Merck Melanoma Drug Is First PD-1 Inhibitor OK'd by FDA"</a>. <i>Genetic Engineering &amp; Biotechnology News</i><span class="reference-accessdate">. Retrieved <span class="nowrap">3 July</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=Merck+Melanoma+Drug+Is+First+PD-1+Inhibitor+OK%27d+by+FDA&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fmerck-melanoma-drug-is-first-pd-1-inhibitor-ok-d-by-fda%2F81250309%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><cite class="citation web"> <span class="cs1-format">(PDF)</span> <a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125514lbl.pdf">http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125514lbl.pdf</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2014%2F125514lbl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span> <span class="cs1-visible-error error citation-comment">Missing or empty <code class="cs1-code">|title=</code> (<a href="/wiki/Help:CS1_errors#citation_missing_title" title="Help:CS1 errors">help</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://homelandprepnews.com/stories/31441-merck-nears-approval-of-experimental-ebola-vaccine/">"Merck nears approval of experimental Ebola vaccine"</a>. <i>Homeland Preparedness News</i>. 2018-11-21<span class="reference-accessdate">. Retrieved <span class="nowrap">2018-11-30</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Homeland+Preparedness+News&amp;rft.atitle=Merck+nears+approval+of+experimental+Ebola+vaccine&amp;rft.date=2018-11-21&amp;rft_id=https%3A%2F%2Fhomelandprepnews.com%2Fstories%2F31441-merck-nears-approval-of-experimental-ebola-vaccine%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.historyofvaccines.org/content/articles/mumps">"Mumps—History of Vaccines"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Mumps%E2%80%94History+of+Vaccines&amp;rft_id=http%3A%2F%2Fwww.historyofvaccines.org%2Fcontent%2Farticles%2Fmumps&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.historyofvaccines.org/content/articles/rubella">"Rubella—History of Vaccines"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Rubella%E2%80%94History+of+Vaccines&amp;rft_id=http%3A%2F%2Fwww.historyofvaccines.org%2Fcontent%2Farticles%2Frubella&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.historyofvaccines.org/content/timelines/measles">"1971-MMR Combination Vaccine Debuts"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=1971-MMR+Combination+Vaccine+Debuts&amp;rft_id=http%3A%2F%2Fwww.historyofvaccines.org%2Fcontent%2Ftimelines%2Fmeasles&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://embryology.med.unsw.edu.au/embryology/index.php?title=Abnormal_Development_-_Rubella_Virus">"Rubella"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2014-09-22</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Rubella&amp;rft_id=http%3A%2F%2Fembryology.med.unsw.edu.au%2Fembryology%2Findex.php%3Ftitle%3DAbnormal_Development_-_Rubella_Virus&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.historyofvaccines.org/content/timelines/others#EVT_100763">"1981-Hepatitis B: First Subunit Viral Vaccine in U.S."</a></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=1981-Hepatitis+B%3A+First+Subunit+Viral+Vaccine+in+U.S.&amp;rft_id=http%3A%2F%2Fwww.historyofvaccines.org%2Fcontent%2Ftimelines%2Fothers%23EVT_100763&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.historyofvaccines.org/content/timelines/others#EVT_100763">"3/17/1995-Chickenpox Vaccine Licensed"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=3%2F17%2F1995-Chickenpox+Vaccine+Licensed&amp;rft_id=http%3A%2F%2Fwww.historyofvaccines.org%2Fcontent%2Ftimelines%2Fothers%23EVT_100763&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><cite class="citation journal">Beyer KH (1993). "Chlorothiazide. How the thiazides evolved as antihypertensive therapy". <i>Hypertension</i>. <b>22</b> (3): 388–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1161%2F01.hyp.22.3.388">10.1161/01.hyp.22.3.388</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/8349332">8349332</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hypertension&amp;rft.atitle=Chlorothiazide.+How+the+thiazides+evolved+as+antihypertensive+therapy&amp;rft.volume=22&amp;rft.issue=3&amp;rft.pages=388-91&amp;rft.date=1993&amp;rft_id=info%3Adoi%2F10.1161%2F01.hyp.22.3.388&amp;rft_id=info%3Apmid%2F8349332&amp;rft.aulast=Beyer&amp;rft.aufirst=KH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails">"Drugs@FDA: FDA Approved Drug Products"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Drugs%40FDA%3A+FDA+Approved+Drug+Products&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fscripts%2Fcder%2Fdrugsatfda%2Findex.cfm%3Ffuseaction%3DSearch.DrugDetails&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.laskerfoundation.org/awards/formaward.htm">"The Lasker Foundation—Awards"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Lasker+Foundation%E2%80%94Awards&amp;rft_id=http%3A%2F%2Fwww.laskerfoundation.org%2Fawards%2Fformaward.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.merck.com/about/our-history/home.html">"Merck History"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2014-09-22</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Merck+History&amp;rft_id=https%3A%2F%2Fwww.merck.com%2Fabout%2Four-history%2Fhome.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><cite class="citation journal">Kingston W (July 2004). "Streptomycin, Schatz v. Waksman, and the balance of credit for discovery". <i>J Hist Med Allied Sci</i>. <b>59</b> (3): 441–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fjhmas%2Fjrh091">10.1093/jhmas/jrh091</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15270337">15270337</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Hist+Med+Allied+Sci&amp;rft.atitle=Streptomycin%2C+Schatz+v.+Waksman%2C+and+the+balance+of+credit+for+discovery&amp;rft.volume=59&amp;rft.issue=3&amp;rft.pages=441-62&amp;rft.date=2004-07&amp;rft_id=info%3Adoi%2F10.1093%2Fjhmas%2Fjrh091&amp;rft_id=info%3Apmid%2F15270337&amp;rft.au=Kingston+W&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text">Antibacterial Agents. Chemistry, Mode of Action, Mechanisms of Resistance, and Clinical Applications. Anderson RJ, Groundwater PJ, Todd A, Worsely AJ. Wiley (2012). <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/9780470972458" title="Special:BookSources/9780470972458">9780470972458</a> See Preface material.</span>
</li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><cite class="citation conference">Tansey, E.M.; Reynolds, L.A., eds. (2000). <span class="cs1-lock-registration" title="Free registration required"><a rel="nofollow" class="external text" href="https://archive.org/details/postpenicillinan00witn"><i>Post-Penicillin Antibiotics: From Acceptance to Resistance?</i></a></span>. A Witness Seminar held at the Wellcome Institute for the History of Medicine, London. London: Wellcome Trust. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-184129-012-6" title="Special:BookSources/978-184129-012-6"><bdi>978-184129-012-6</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=conference&amp;rft.btitle=Post-Penicillin+Antibiotics%3A+From+Acceptance+to+Resistance%3F&amp;rft.place=London&amp;rft.pub=Wellcome+Trust&amp;rft.date=2000&amp;rft.isbn=978-184129-012-6&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Fpostpenicillinan00witn&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-88">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://cid.oxfordjournals.org/content/50/2/133.full.pdf+html">"Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Diagnosis+and+Management+of+Complicated+Intra-abdominal+Infection+in+Adults+and+Children%3A+Guidelines+by+the+Surgical+Infection+Society+and+the+Infectious+Diseases+Society+of+America&amp;rft_id=http%3A%2F%2Fcid.oxfordjournals.org%2Fcontent%2F50%2F2%2F133.full.pdf%2Bhtml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text"><cite class="citation web"> <span class="cs1-format">(PDF)</span> <a rel="nofollow" class="external text" href="http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/HAP.pdf">http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/HAP.pdf</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.idsociety.org%2FuploadedFiles%2FIDSA%2FGuidelines-Patient_Care%2FPDF_Library%2FHAP.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span> <span class="cs1-visible-error error citation-comment">Missing or empty <code class="cs1-code">|title=</code> (<a href="/wiki/Help:CS1_errors#citation_missing_title" title="Help:CS1 errors">help</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><cite class="citation journal">Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, Bloch DA (February 1989). "Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use". <i>Gastroenterology</i>. <b>96</b> (2 Pt 2 Suppl): 647–55. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0016-5085%2889%2980061-7">10.1016/S0016-5085(89)80061-7</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/2909442">2909442</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gastroenterology&amp;rft.atitle=Toward+an+epidemiology+of+gastropathy+associated+with+nonsteroidal+antiinflammatory+drug+use&amp;rft.volume=96&amp;rft.issue=2+Pt+2+Suppl&amp;rft.pages=647-55&amp;rft.date=1989-02&amp;rft_id=info%3Adoi%2F10.1016%2FS0016-5085%2889%2980061-7&amp;rft_id=info%3Apmid%2F2909442&amp;rft.aulast=Fries&amp;rft.aufirst=JF&amp;rft.au=Miller%2C+SR&amp;rft.au=Spitz%2C+PW&amp;rft.au=Williams%2C+CA&amp;rft.au=Hubert%2C+HB&amp;rft.au=Bloch%2C+DA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-91">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://finance.senate.gov/press/Gpress/2004/prg101504.pdf">Finance.senate.gov</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20041029135457/http://finance.senate.gov/press/Gpress/2004/prg101504.pdf">Archived</a> October 29, 2004, at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-92">^</a></b></span> <span class="reference-text"><cite class="citation journal">Vaithianathan R, Hockey PM, Moore TJ, Bates DW (2009). "Iatrogenic effects of COX-2 inhibitors in the US population: findings from the Medical Expenditure Panel Survey". <i>Drug Saf</i>. <b>32</b> (4): 335–43. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2165%2F00002018-200932040-00007">10.2165/00002018-200932040-00007</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19388724">19388724</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Saf&amp;rft.atitle=Iatrogenic+effects+of+COX-2+inhibitors+in+the+US+population%3A+findings+from+the+Medical+Expenditure+Panel+Survey&amp;rft.volume=32&amp;rft.issue=4&amp;rft.pages=335-43&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.2165%2F00002018-200932040-00007&amp;rft_id=info%3Apmid%2F19388724&amp;rft.aulast=Vaithianathan&amp;rft.aufirst=R&amp;rft.au=Hockey%2C+PM&amp;rft.au=Moore%2C+TJ&amp;rft.au=Bates%2C+DW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-NYT-93"><span class="mw-cite-backlink">^ <a href="#cite_ref-NYT_93-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NYT_93-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2008/05/30/business/30drug.html?_r=1&amp;partner=rssnyt&amp;emc=rss&amp;oref=slogin">Courts Reject Two Major Vioxx Verdicts</a>, <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a>, May 30, 2008</i></span>
</li>
<li id="cite_note-NYT2-94"><span class="mw-cite-backlink">^ <a href="#cite_ref-NYT2_94-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NYT2_94-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2007/11/09/business/09cnd-merck.html">"Merck Agrees to Pay $4.85 Billion in Vioxx Claims"</a>. <i>The New York Times</i>. November 9, 2007.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Merck+Agrees+to+Pay+%244.85+Billion+in+Vioxx+Claims&amp;rft.date=2007-11-09&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2007%2F11%2F09%2Fbusiness%2F09cnd-merck.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-95">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.officialvioxxsettlement.com/documents/Description%20of%20Settlement.pdf">"Description of Settlement Agreement"</a> <span class="cs1-format">(PDF)</span>. <i>Vioxx MDL Plaintiffs’ Steering Committee Official Vioxx Settlement</i>. November 9, 2007.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Vioxx+MDL+Plaintiffs%E2%80%99+Steering+Committee+Official+Vioxx+Settlement&amp;rft.atitle=Description+of+Settlement+Agreement&amp;rft.date=2007-11-09&amp;rft_id=http%3A%2F%2Fwww.officialvioxxsettlement.com%2Fdocuments%2FDescription%2520of%2520Settlement.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><cite class="citation web">Giles, J. (November 2008). <a rel="nofollow" class="external text" href="http://www.healthyskepticism.org/global/library/item/14482">"How Merck Made a Killing"</a>. <i>Healthy Scepticism</i>. Archived from <a rel="nofollow" class="external text" href="http://www.prospect-magazine.co.uk/article_details.php?id=10425">the original</a> on August 2018.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Healthy+Scepticism&amp;rft.atitle=How+Merck+Made+a+Killing&amp;rft.date=2008-11&amp;rft.aulast=Giles&amp;rft.aufirst=J.&amp;rft_id=http%3A%2F%2Fwww.prospect-magazine.co.uk%2Farticle_details.php%3Fid%3D10425&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-97">^</a></b></span> <span class="reference-text"><cite class="citation news">Rout, Milanda (April 1, 2009). <a rel="nofollow" class="external text" href="http://www.theaustralian.com.au/drug-company-drew-up-doctor-hit-list/story-fna7dq6e-1225693586492">"Vioxx maker Merck and Co drew up doctor hit list"</a>. <i>The Australian</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-26</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Australian&amp;rft.atitle=Vioxx+maker+Merck+and+Co+drew+up+doctor+hit+list&amp;rft.date=2009-04-01&amp;rft.aulast=Rout&amp;rft.aufirst=Milanda&amp;rft_id=http%3A%2F%2Fwww.theaustralian.com.au%2Fdrug-company-drew-up-doctor-hit-list%2Fstory-fna7dq6e-1225693586492&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://ktar.com/?nid=6&amp;sid=842595&amp;r=1">Arizona gets $2.3 Million from Vioxx Settlement</a> <a href="/wiki/KTAR-FM" title="KTAR-FM">92.3 KTAR</a> Retrieved May 19, 2008</span>
</li>
<li id="cite_note-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-99">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2008/05/21/business/21vioxx.html?_r=1&amp;ref=business&amp;oref=slogin">Merck Agrees to Settlement Over Vioxx Ads</a>, <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>, May 20, 2008</span>
</li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120426154146/http://www.unicefusa.org/news/news-from-the-field/merck-pia.html">"Stories of UNICEF in Action"</a>. <i>UNICEF USA</i>. Archived from the original on 26 April 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">3 July</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=UNICEF+USA&amp;rft.atitle=Stories+of+UNICEF+in+Action&amp;rft_id=http%3A%2F%2Fwww.unicefusa.org%2Fnews%2Fnews-from-the-field%2Fmerck-pia.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: BOT: original-url status unknown (<a href="/wiki/Category:CS1_maint:_BOT:_original-url_status_unknown" title="Category:CS1 maint: BOT: original-url status unknown">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.stanford.edu/class/humbio103/ParaSites2005/Ivermectin/History.htm">"Ivermectin History"</a>. Stanford.edu. February 24, 1981<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-06-05</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Ivermectin+History&amp;rft.pub=Stanford.edu&amp;rft.date=1981-02-24&amp;rft_id=http%3A%2F%2Fwww.stanford.edu%2Fclass%2Fhumbio103%2FParaSites2005%2FIvermectin%2FHistory.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110830090427/http://www.un.org/ecosocdev/geninfo/afrec/vol17no1/171heal1.htm">Onchocerciasis: Africa's victory over river blindness</a>, Africa Recovery, Vol. 17 No. 1 (May 2003), p. 6</span>
</li>
<li id="cite_note-Mectizan_Donation_Program-103"><span class="mw-cite-backlink">^ <a href="#cite_ref-Mectizan_Donation_Program_103-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Mectizan_Donation_Program_103-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.mectizan.org/history">"History"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">3 July</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=History&amp;rft_id=http%3A%2F%2Fwww.mectizan.org%2Fhistory&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-104">^</a></b></span> <span class="reference-text"><cite class="citation journal">"Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society". <i>Menopause</i>. <b>17</b> (1): 25–54, quiz 55–6. 2010. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2Fgme.0b013e3181c617e6">10.1097/gme.0b013e3181c617e6</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20061894">20061894</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Menopause&amp;rft.atitle=Management+of+osteoporosis+in+postmenopausal+women%3A+2010+position+statement+of+The+North+American+Menopause+Society&amp;rft.volume=17&amp;rft.issue=1&amp;rft.pages=25-54%2C+quiz+55-6&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1097%2Fgme.0b013e3181c617e6&amp;rft_id=info%3Apmid%2F20061894&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-105">^</a></b></span> <span class="reference-text"><cite class="citation journal">Hauk L (August 2013). "ACOG releases practice bulletin on osteoporosis". <i>Am Fam Physician</i>. <b>88</b> (4): 269–75. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23944732">23944732</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+Fam+Physician&amp;rft.atitle=ACOG+releases+practice+bulletin+on+osteoporosis&amp;rft.volume=88&amp;rft.issue=4&amp;rft.pages=269-75&amp;rft.date=2013-08&amp;rft_id=info%3Apmid%2F23944732&amp;rft.au=Hauk+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-106">^</a></b></span> <span class="reference-text"><cite class="citation journal">Compston J, Bowring C, Cooper A,  et al. (August 2013). "Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013". <i>Maturitas</i>. <b>75</b> (4): 392–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.maturitas.2013.05.013">10.1016/j.maturitas.2013.05.013</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23810490">23810490</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Maturitas&amp;rft.atitle=Diagnosis+and+management+of+osteoporosis+in+postmenopausal+women+and+older+men+in+the+UK%3A+National+Osteoporosis+Guideline+Group+%28NOGG%29+update+2013&amp;rft.volume=75&amp;rft.issue=4&amp;rft.pages=392-6&amp;rft.date=2013-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.maturitas.2013.05.013&amp;rft_id=info%3Apmid%2F23810490&amp;rft.aulast=Compston&amp;rft.aufirst=J&amp;rft.au=Bowring%2C+C&amp;rft.au=Cooper%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-107">^</a></b></span> <span class="reference-text"><cite class="citation web"> <span class="cs1-format">(PDF)</span> <a rel="nofollow" class="external text" href="https://www.aace.com/files/osteo-guidelines-2010.pdf">https://www.aace.com/files/osteo-guidelines-2010.pdf</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft_id=https%3A%2F%2Fwww.aace.com%2Ffiles%2Fosteo-guidelines-2010.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span> <span class="cs1-visible-error error citation-comment">Missing or empty <code class="cs1-code">|title=</code> (<a href="/wiki/Help:CS1_errors#citation_missing_title" title="Help:CS1 errors">help</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-108">^</a></b></span> <span class="reference-text"><cite class="citation journal">Eriksen EF, Díez-Pérez A, Boonen S (January 2014). "Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: a systematic review". <i>Bone</i>. <b>58</b>: 126–35. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.bone.2013.09.023">10.1016/j.bone.2013.09.023</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24120384">24120384</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bone&amp;rft.atitle=Update+on+long-term+treatment+with+bisphosphonates+for+postmenopausal+osteoporosis%3A+a+systematic+review&amp;rft.volume=58&amp;rft.pages=126-35&amp;rft.date=2014-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bone.2013.09.023&amp;rft_id=info%3Apmid%2F24120384&amp;rft.aulast=Eriksen&amp;rft.aufirst=EF&amp;rft.au=D%C3%ADez-P%C3%A9rez%2C+A&amp;rft.au=Boonen%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text"><cite class="citation journal">Serrano AJ, Begoña L, Anitua E, Cobos R, Orive G (December 2013). "Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis". <i>Gynecol. Endocrinol</i>. <b>29</b> (12): 1005–14. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F09513590.2013.813468">10.3109/09513590.2013.813468</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24063695">24063695</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gynecol.+Endocrinol.&amp;rft.atitle=Systematic+review+and+meta-analysis+of+the+efficacy+and+safety+of+alendronate+and+zoledronate+for+the+treatment+of+postmenopausal+osteoporosis&amp;rft.volume=29&amp;rft.issue=12&amp;rft.pages=1005-14&amp;rft.date=2013-12&amp;rft_id=info%3Adoi%2F10.3109%2F09513590.2013.813468&amp;rft_id=info%3Apmid%2F24063695&amp;rft.aulast=Serrano&amp;rft.aufirst=AJ&amp;rft.au=Bego%C3%B1a%2C+L&amp;rft.au=Anitua%2C+E&amp;rft.au=Cobos%2C+R&amp;rft.au=Orive%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><cite class="citation journal">Gauthier K, Bai A, Perras C,  et al. (2012). "Denosumab, Raloxifene, and Zoledronic Acid for the Treatment of Postmenopausal Osteoporosis: Clinical Effectiveness and Harms [Internet]". <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24278999">24278999</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Denosumab%2C+Raloxifene%2C+and+Zoledronic+Acid+for+the+Treatment+of+Postmenopausal+Osteoporosis%3A+Clinical+Effectiveness+and+Harms+%5BInternet%5D.&amp;rft.date=2012&amp;rft_id=info%3Apmid%2F24278999&amp;rft.aulast=Gauthier&amp;rft.aufirst=K&amp;rft.au=Bai%2C+A&amp;rft.au=Perras%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span> <span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code">|journal=</code> (<a href="/wiki/Help:CS1_errors#missing_periodical" title="Help:CS1 errors">help</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-111">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/2013/12/09/us-merck-fosamax-idUSBRE9B811S20131209">"Merck agrees to proposed $27.7 million settlement over Fosamax lawsuits | Reuters"</a>. <i>Reuters</i>. 2013-12-09.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Merck+agrees+to+proposed+%2427.7+million+settlement+over+Fosamax+lawsuits+%26%23124%3B+Reuters&amp;rft.date=2013-12-09&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2013%2F12%2F09%2Fus-merck-fosamax-idUSBRE9B811S20131209&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.merck.com/newsroom/press_releases/corporate/2006_0526.html">"Merck to Create New Patient Assistance Program for Vaccines"</a> Retrieved May 20, 2008. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20080916195646/http://www.merck.com/newsroom/press_releases/corporate/2006_0526.html">Archived</a> September 16, 2008, at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-113">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://patientassistance.com/programs.html?pharmaname=merck+%26+co&amp;medication=&amp;submit=Search">"Patient Assistance – Available Prescription Assistance Programs From Merck &amp; Co."</a> Retrieved May 20, 2008.</span>
</li>
<li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.merck.com/responsibility/pap-information.html">Merck Patient Assistance Programs</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110727152434/http://www.merck.com/responsibility/pap-information.html">Archived</a> July 27, 2011, at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-Fierce2015-115"><span class="mw-cite-backlink">^ <a href="#cite_ref-Fierce2015_115-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Fierce2015_115-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Staton, Tracy (August 13, 2015). <a rel="nofollow" class="external text" href="https://www.fiercepharma.com/corporate/merck-tallies-36-000-job-cuts-5-years-of-restructuring">"Merck tallies 36,000 job cuts in 5 years of restructuring"</a>. <i>FiercePharma</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Merck+tallies+36%2C000+job+cuts+in+5+years+of+restructuring&amp;rft.date=2015-08-13&amp;rft.aulast=Staton&amp;rft.aufirst=Tracy&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fcorporate%2Fmerck-tallies-36-000-job-cuts-5-years-of-restructuring&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><cite class="citation news">Singer N (May 13, 2009). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2009/05/14/business/14vioxxside.html">"Merck paid for medical 'journal' without disclosure"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2009-06-17</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Merck+paid+for+medical+%27journal%27+without+disclosure&amp;rft.date=2009-05-13&amp;rft.au=Singer+N&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F05%2F14%2Fbusiness%2F14vioxxside.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://www.elsevier.com/about/press-releases/clinical-solutions/statement-from-michael-hansen,-ceo-of-elseviers-health-sciences-division,-regarding-australia-based-sponsored-journal-practices-between-2000-and-2005">"Statement from Michael Hansen, CEO of Elsevier's Health Sciences Division, Regarding Australia Based Sponsored Journal Practices Between 2000 and 2005"</a> (Press release). <a href="/wiki/Elsevier" title="Elsevier">Elsevier</a>. May 7, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>. <q>It has recently come to my attention that from 2000 to 2005, our Australia office published a series of sponsored article compilation publications, on behalf of pharmaceutical clients, that were made to look like journals and lacked the proper disclosures. This was an unacceptable practice, and we regret that it took place.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Statement+from+Michael+Hansen%2C+CEO+of+Elsevier%27s+Health+Sciences+Division%2C+Regarding+Australia+Based+Sponsored+Journal+Practices+Between+2000+and+2005&amp;rft.pub=Elsevier&amp;rft.date=2009-05-07&amp;rft_id=https%3A%2F%2Fwww.elsevier.com%2Fabout%2Fpress-releases%2Fclinical-solutions%2Fstatement-from-michael-hansen%2C-ceo-of-elseviers-health-sciences-division%2C-regarding-australia-based-sponsored-journal-practices-between-2000-and-2005&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.fiercevaccines.com/story/merck-jv-plans-show-jj-sanofi-low-cost-cholera-vax/2014-06-19">"Fierce Biotech: Merck JV plans to show up J&amp;J, Sanofi with low-cost cholera vaccine"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2015-02-07</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Fierce+Biotech%3A+Merck+JV+plans+to+show+up+J%26J%2C+Sanofi+with+low-cost+cholera+vaccine&amp;rft_id=http%3A%2F%2Fwww.fiercevaccines.com%2Fstory%2Fmerck-jv-plans-show-jj-sanofi-low-cost-cholera-vax%2F2014-06-19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-wapo-119"><span class="mw-cite-backlink">^ <a href="#cite_ref-wapo_119-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-wapo_119-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Johnson, Carrie (February 8, 2008). <a rel="nofollow" class="external text" href="https://www.washingtonpost.com/wp-dyn/content/article/2008/02/07/AR2008020701336.html">"Merck to Pay $650 Million In Medicaid Settlement"</a>. <i>The Washington Post</i><span class="reference-accessdate">. Retrieved <span class="nowrap">February 8,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=Merck+to+Pay+%24650+Million+In+Medicaid+Settlement&amp;rft.date=2008-02-08&amp;rft.aulast=Johnson&amp;rft.aufirst=Carrie&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2008%2F02%2F07%2FAR2008020701336.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.justice.gov/opa/pr/2008/February/08_civ_094.html">"Merck to Pay More than $650 Million to Resolve Claims of Fraudulent Price Reporting and Kickbacks"</a>. US Department of Justice. February 7, 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-06-05</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Merck+to+Pay+More+than+%24650+Million+to+Resolve+Claims+of+Fraudulent+Price+Reporting+and+Kickbacks&amp;rft.pub=US+Department+of+Justice&amp;rft.date=2008-02-07&amp;rft_id=http%3A%2F%2Fwww.justice.gov%2Fopa%2Fpr%2F2008%2FFebruary%2F08_civ_094.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-121">^</a></b></span> <span class="reference-text"><cite class="citation web">Silverman, Ed (February 7, 2008). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20120429114103/http://www.pharmalot.com/2008/02/merck-to-pay-650m-over-medicaid-fraud/">"Merck To Pay $670 Million Over Medicaid Fraud"</a>. Pharmalot.com. Archived from <a rel="nofollow" class="external text" href="http://www.pharmalot.com/2008/02/merck-to-pay-650m-over-medicaid-fraud/">the original</a> on April 29, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-06-05</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Merck+To+Pay+%24670+Million+Over+Medicaid+Fraud&amp;rft.pub=Pharmalot.com&amp;rft.date=2008-02-07&amp;rft.aulast=Silverman&amp;rft.aufirst=Ed&amp;rft_id=http%3A%2F%2Fwww.pharmalot.com%2F2008%2F02%2Fmerck-to-pay-650m-over-medicaid-fraud%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-122">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.merck.com/newsroom/news-release-archive/corporate/2008_0207.html">"Merck Resolves Federal and State Investigations Related to Certain Past Pricing And Certain Past Sales and Marketing Activities"</a>. Merck. February 7, 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">February 8,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Merck+Resolves+Federal+and+State+Investigations+Related+to+Certain+Past+Pricing+And+Certain+Past+Sales+and+Marketing+Activities&amp;rft.date=2008-02-07&amp;rft_id=https%3A%2F%2Fwww.merck.com%2Fnewsroom%2Fnews-release-archive%2Fcorporate%2F2008_0207.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-123">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://infohouse.p2ric.org/ref/01/00155.pdf">"P2ric.org Is For Sale"</a> <span class="cs1-format">(PDF)</span>. <i>infohouse.p2ric.org</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=infohouse.p2ric.org&amp;rft.atitle=P2ric.org+Is+For+Sale&amp;rft_id=http%3A%2F%2Finfohouse.p2ric.org%2Fref%2F01%2F00155.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-124">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://yosemite.epa.gov/opa/admpress.nsf/016bcfb1deb9fecd85256aca005d74df/e96f05f182d3254b852570d8005e1207!OpenDocument">"U.S. settles $1.8 million pollution case with Merck and Monsanto | US EPA"</a>. Yosemite.epa.gov<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-06-05</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=U.S.+settles+%241.8+million+pollution+case+with+Merck+and+Monsanto+%26%23124%3B+US+EPA&amp;rft.pub=Yosemite.epa.gov&amp;rft_id=http%3A%2F%2Fyosemite.epa.gov%2Fopa%2Fadmpress.nsf%2F016bcfb1deb9fecd85256aca005d74df%2Fe96f05f182d3254b852570d8005e1207%21OpenDocument&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-125">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://uk.reuters.com/article/us-health-global-gff/donors-pledge-1-billion-for-maternal-and-child-health-fund-idUKKCN1NB1PX">"Donors pledge $1 billion for maternal and child health fund"</a>. <i>Reuters</i>. 6 November 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">6 February</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Donors+pledge+%241+billion+for+maternal+and+child+health+fund&amp;rft.date=2018-11-06&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-health-global-gff%2Fdonors-pledge-1-billion-for-maternal-and-child-health-fund-idUKKCN1NB1PX&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMerck+%26+Co." class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
</ol></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(8)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><a href="/w/index.php?title=Merck_%26_Co.&amp;action=edit&amp;section=31" title="Edit section: External links" data-section="31" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-8 collapsible-block" id="mf-section-8">
<table role="presentation" class="mbox-small plainlinks sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000"><tbody><tr>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="https://commons.wikimedia.org/wiki/Category:Merck_%26_Co.,_Inc." class="extiw" title="commons:Category:Merck &amp; Co., Inc."><span style="">Merck &amp; Co., Inc.</span></a></b></i>.</td></tr></tbody></table><ul><li><a rel="nofollow" class="external text" href="http://www.merck.com/about/">About Merck &amp; Co.</a></li>
<li><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120302015332/http://www.merckmanuals.com/">The Merck Manuals</a></li>
<li>Business data for Merck &amp; Co.: <div class="hlist hlist-separated inline"><ul><li><a rel="nofollow" class="external text" href="https://www.google.com/finance?q=MRK">Google Finance</a></li><li><a rel="nofollow" class="external text" href="https://finance.yahoo.com/q?s=MRK">Yahoo! Finance</a></li><li><a rel="nofollow" class="external text" href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=MRK">SEC filings</a></li></ul></div></li>
<li><a rel="nofollow" class="external text" href="http://www.merckfrosst.ca/">Merck in Canada</a></li></ul> 









</section></div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1&amp;mobile=1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Merck_%26_Co.&amp;oldid=950921372">https://en.wikipedia.org/w/index.php?title=Merck_%26_Co.&amp;oldid=950921372</a>"</div>
</div>
			<div class="post-content" id="page-secondary-actions">
			
			</div>
		</main>
		<footer class="minerva-footer">
		<div class="last-modified-bar">
	<div class="post-content last-modified-bar__content">
		<span class="last-modified-bar__icon mw-ui-icon mw-ui-icon-mw-ui-icon-small mw-ui-icon-wikimedia-history-base20 "></span>
		<a class="last-modified-bar__text" href="/wiki/Special:History/Merck_%26_Co."
				data-user-name="OAbot"
				data-user-gender="unknown"
				data-timestamp="1586877263">
				<span>Last edited on 14 April 2020, at 15:14</span>
		</a>
		<span class="mw-ui-icon mw-ui-icon-small mw-ui-icon-mf-expand-gray mf-mw-ui-icon-rotate-anti-clockwise indicator"></span>
	</div>
</div>

		<div class="post-content footer-content">
			<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

			<h2><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></h2>
			<div class="license">Content is available under <a class="external" rel="nofollow" href="https://creativecommons.org/licenses/by-sa/3.0/">CC BY-SA 3.0</a> unless otherwise noted.</div>
			<ul class="footer-places hlist hlist-separated">
				<li id="footer-places-terms-use"><a href="//m.wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a></li><li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy</a></li><li id="footer-places-desktop-toggle"><a id="mw-mf-display-toggle" href="//en.wikipedia.org/w/index.php?title=Merck_%26_Co.&amp;mobileaction=toggle_view_desktop">Desktop</a></li>
			</ul>
		</div>
		</footer>
	</div>
</div>
<div class="mw-notification-area" data-mw="interface"></div>
<!-- v:8.3.0 -->

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"1.240","walltime":"1.585","ppvisitednodes":{"value":7678,"limit":1000000},"postexpandincludesize":{"value":285551,"limit":2097152},"templateargumentsize":{"value":12784,"limit":2097152},"expansiondepth":{"value":15,"limit":40},"expensivefunctioncount":{"value":10,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":360513,"limit":5000000},"entityaccesscount":{"value":4,"limit":400},"timingprofile":["100.00% 1393.603      1 -total"," 48.47%  675.422      1 Template:Reflist"," 18.26%  254.482     56 Template:Cite_web"," 14.42%  200.915      1 Template:Infobox_company"," 13.34%  185.843      1 Template:Infobox","  8.98%  125.148     16 Template:Cite_journal","  7.45%  103.768     10 Template:Fix","  7.28%  101.463      7 Template:Citation_needed","  7.08%   98.684     28 Template:Cite_news","  5.09%   70.989      1 Template:Br_separated_entries"]},"scribunto":{"limitreport-timeusage":{"value":"0.652","limit":"10.000"},"limitreport-memusage":{"value":12340805,"limit":52428800}},"cachereport":{"origin":"mw1371","timestamp":"20200416051136","ttl":86400,"transientcontent":true}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Merck & Co.","url":"https:\/\/en.wikipedia.org\/wiki\/Merck_%26_Co.","sameAs":"http:\/\/www.wikidata.org\/entity\/Q247489","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q247489","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2004-08-29T01:48:53Z","dateModified":"2020-04-14T15:14:23Z","headline":"American pharmaceutical company and former subsidiary of the German Merck company"}</script><script>(window.NORLQ=window.NORLQ||[]).push(function(){var ns,i,p,img;ns=document.getElementsByTagName('noscript');for(i=0;i<ns.length;i++){p=ns[i].nextSibling;if(p&&p.className&&p.className.indexOf('lazy-image-placeholder')>-1){img=document.createElement('img');img.setAttribute('src',p.getAttribute('data-src'));img.setAttribute('width',p.getAttribute('data-width'));img.setAttribute('height',p.getAttribute('data-height'));img.setAttribute('alt',p.getAttribute('data-alt'));p.parentNode.replaceChild(img,p);}}});</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":261,"wgHostname":"mw1330"});});</script>		</body>
		</html>
		